The present invention relates to compounds for use as emitters, and devices, such as organic light emitting diodes, including the same.
Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.
OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.
One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single EML device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.
One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy)3, which has the following structure:
In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.
As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.
As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.
As used herein, “solution processible” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.
A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.
As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative) Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.
As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.
More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.
A compound comprising a first ligand LA of Formula I,
is disclosed.
In Formula I, ring A is a 5- or 6-membered carbocyclic or heterocyclic ring. Each of RA and RB independently represents none to a maximum possible number of substitutions. Each of R1, R2, RA, and RB is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. Z1 is carbon or nitrogen. Any R1, R2, RA, and RB are optionally joined or fused into a ring. The ligand LA is coordinated to a metal M. LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand. M is optionally coordinated to other ligands.
An organic light emitting device (OLED) incorporating the compound of the present disclosure is also disclosed. The OLED comprises an anode, a cathode, and an organic layer, disposed between the anode and the cathode. The organic layer comprises the inventive compound of the present disclosure.
A consumer product comprising the OLED is also disclosed.
Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.
The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.
More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.
More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F4-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.
The simple layered structure illustrated in
Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in
Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink jet and OVJD. Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processibility than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.
Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.
Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. A consumer product comprising an OLED that includes the compound of the present disclosure in the organic layer in the OLED is disclosed. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, micro-displays (displays that are less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls comprising multiple displays tiled together, theater or stadium screen, and a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.), but could be used outside this temperature range, for example, from −40 degree C. to +80 degree C.
The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.
The term “halo,” “halogen,” or “halide” as used herein includes fluorine, chlorine, bromine, and iodine.
The term “alkyl” as used herein contemplates both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group may be optionally substituted.
The term “cycloalkyl” as used herein contemplates cyclic alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 10 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, adamantyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.
The term “alkenyl” as used herein contemplates both straight and branched chain alkene radicals. Preferred alkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl group may be optionally substituted.
The term “alkynyl” as used herein contemplates both straight and branched chain alkyne radicals. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group may be optionally substituted.
The terms “aralkyl” or “arylalkyl” as used herein are used interchangeably and contemplate an alkyl group that has as a substituent an aromatic group. Additionally, the aralkyl group may be optionally substituted.
The term “heterocyclic group” as used herein contemplates aromatic and non-aromatic cyclic radicals. Hetero-aromatic cyclic radicals also means heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 to 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperidino, pyrrolidino, and the like, and cyclic ethers, such as tetrahydrofuran, tetrahydropyran, and the like. Additionally, the heterocyclic group may be optionally substituted.
The term “aryl” or “aromatic group” as used herein contemplates single-ring groups and polycyclic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is aromatic, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group may be optionally substituted.
The term “heteroaryl” as used herein contemplates single-ring hetero-aromatic groups that may include from one to five heteroatoms. The term heteroaryl also includes polycyclic hetero-aromatic systems having two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine, and aza-analogs thereof. Additionally, the heteroaryl group may be optionally substituted.
The alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl may be unsubstituted or may be substituted with one or more substituents selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, cyclic amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.
As used herein, “substituted” indicates that a substituent other than H is bonded to the relevant position, such as carbon. Thus, for example, where R′ is mono-substituted, then one R′ must be other than H. Similarly, where R′ is di-substituted, then two of R′ must be other than H. Similarly, where R′ is unsubstituted, R′ is hydrogen for all available positions. The maximum number of substitutions possible in a structure will depend on the number of atoms with available valencies.
The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective fragment can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.
It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.
A compound comprising a first ligand LA of Formula I:
is disclosed. In Formula I, ring A is a 5- or 6-membered carbocyclic or heterocyclic ring. Each of RA and RB independently represents none to a maximum possible number of substitutions. Each of R1, R2, RA, and RB is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. Z1 is carbon or nitrogen. Any R1, R2, RA, and RB are optionally joined or fused into a ring. The ligand LA is coordinated to a metal M. LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand. M is optionally coordinated to other ligands.
In some embodiments of the compound, each of R1, R2, RA, and RB is independently selected from the group consisting of hydrogen, deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, and combinations thereof.
In some embodiments of the compound, M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu. In some embodiments, M is Ir or Pt.
In some embodiments of the compound, the compound is homoleptic. In some embodiments, the compound is heteroleptic.
In some embodiments of the compound, ring A is a 6-membered aromatic ring. In some embodiments, ring A is a 5-membered aromatic ring. In some embodiments, ring A is a benzene ring.
In some embodiments of the compound, Z1 is an anionic coordinating atom selected from the group consisting of C, N, and O. In some embodiments, the anionic coordinating carbon is an sp2 carbon atom of an aromatic ring, wherein the aromatic ring is selected from the group consisting of benzene, pyridine, furan, thiophene, and pyrrole; wherein the anionic coordinating nitrogen is an sp2 nitrogen atom of an N-heterocyclic ring selected from the group consisting of imidazole, benzimidazole, pyrazole, and triazole; and wherein the anionic oxygen atom is oxygen atom from carboxylic acid or ether.
In some embodiments of the compound, two RB are fused into an aromatic ring.
In some embodiments of the compound, m the first ligand LA selected from the group consisting of:
wherein X and Y are each independently selected from the group consisting of O, S, Se, NR3 and CR4R5; and wherein R3, R4, and R5 have the same definition as R′.
In some embodiments of the compound, the first ligand LA is selected from the group consisting of:
LA1 through LA20 having the structure
wherein in LA1, R1═R2=Me, in LA2, R1═R2=Et, in LA3, R1═R2=iPr, in LA4, R1=Me, R2=Et, in LA5, R1=Me, R2=iPr, in LA6, R1=Et, R2=iPr, in LA7, R1=Me, R2=Ph, in LA8, R1=Et, R2=Ph, in LA9, R1═R2=Ph, in LA10, R1═R2═F, in LA11, R1=Me, R2═CH2CF3, in LA12, R1═R2=CD3, in LA13, R1═R2=CD2CD3, in LA14, R1═R2=CD(CH3)2, in LA15, R1=CD3, R2=CD2CD3, in LA16, R1=CD3, R2=CD(CH3)2, in LA17, R1=CD2CD3, R2=CD(CH3)2, in LA18, R1=CD3, R2=Ph, in LA19, R1=CD2CD3, R2=Ph, and in LA20, R1=CD3, R2=CD2CF3,
LA41 through LA60 having the structure
wherein in LA41, R1═R2=Me, in LA42, R1═R2=Et, in LA43, R1-R2=iPr, in LA44, R1=Me, R2=Et, in LA45, R1=Me, R2=iPr, in LA46, R1=Et, R2=iPr, in LA47, R1=Me, R2=Ph, in LA48, R1=Et, R2=Ph, in LA49, R1═R2=Ph, in LA50, R1═R2═F, in LA51, R1=Me, R2═CH2CF3, in LA52, R1═R2=CD3, in LA53, R1═R2=CD2CD3, in LA54, R1═R2=CD(CH3)2, in LA55, R1=CD3, R2=CD2CD3, in LA56, R1=CD3, R2=CD(CH3)2, in LA57, R1=CD2CD3, R2=CD(CH3)2, in LA58, R1=CD3, R2=Ph, in LA59, R1=CD2CD3, R2=Ph, and in LA60, R1=CD3, R2=CD2CF3,
LA67 through LA86 having the structure
wherein in LA67, R1═R2=Me, in LA68, R1═R2=Et, in LA69, R1═R2=iPr, in LA70, R1=Me, R2=Et, in LA71, R1=Me, R2=iPr, in LA72, R1=Et, R2=iPr, in LA73, R1=Me, R2=Ph, in LA74, R1=Et, R2=Ph, in LA75, R1═R2=Ph, in LA76, R1═R2═F, in LA77, R1=Me, R2═CH2CF3, in LA78, R1═R2=CD3, in LA79, R1═R2=CD2CD3, in LA80, R1═R2=CD(CH3)2, in LA81, R1=CD3, R2=CD2CD3, in LA82, R1=CD3, R2=CD(CH3)2, in LA83, R1=CD2CD3, R2=CD(CH3)2, in LA84, R1=CD3, R2=Ph, in LA85, R1=CD2CD3, R2=Ph, and in LA86, R1=CD3, R2=CD2CF3,
LA93 through LA112 having the structure
wherein in LA93, R1═R2=Me, in LA94, R1═R2=Et, in LA95, R1═R2=iPr, in LA96, R1=Me, R2=Et, in LA97, R1=Me, R2=iPr, in LA98, R1=Et, R2=iPr, in LA99, R1=Me, R2=Ph, in LA100, R1=Et, R2=Ph, in LA101, R1═R2=Ph, in LA102, R1═R2═F, in LA103, R1=Me, R2═CH2CF3, in LA104, R1═R2=CD3, in LA105, R1═R2=CD2CD3, in LA106, R1═R2=CD(CH3)2, in LA107, R1=CD3, R2=CD2CD3, in LA108, R1=CD3, R2=CD(CH3)2, in LA109, R1=CD2CD3, R2=CD(CH3)2, in LA110, R1=CD3, R2=Ph, in LA111, R1=CD2CD3, R2=Ph, and in LA112, R1=CD3, R2=CD2CF3,
LA119 through LA138 having the structure
wherein in LA119, R1═R2=Me, in LA120, R1═R2=Et, in LA121, R1═R2=iPr, in LA122, R1=Me, R2=Et, in LA123, R1=Me, R2=iPr, in LA124, R1=Et, R2=iPr, in LA125, R1=Me, R2=Ph, in LA126, R1=Et, R2=Ph, in LA127, R1═R2=Ph, in LA128, R1═R2═F, in LA129, R1=Me, R2═CH2CF3, in LA130, R1═R2=CD3, in LA131, R1═R2=CD2CD3, in LA132, R1═R2=CD(CH3)2, in LA133, R1=CD3, R2=CD2CD3, in LA134, R1=CD3, R2=CD(CH3)2, in LA135, R1=CD2CD3, R2=CD(CH3)2, in LA136, R1=CD3, R2=Ph, in LA137, R1=CD2CD3, R2=Ph, and in LA138, R1=CD3, R2=CD2CF3,
LA145 through LA164 having the structure
wherein in LA145, R1═R2=Me, in LA146, R1═R2=Et, in LA147, R1═R2=iPr, in LA148, R1=Me, R2=Et, in LA149, R1=Me, R2=iPr, in LA150, R1=Et, R2=iPr, in LA151, R1=Me, R2=Ph, in LA152, R1=Et, R2=Ph, in LA153, R1═R2=Ph, in LA154, R1═R2═F, in LA155, R1=Me, R2═CH2CF3, in LA156, R1═R2=CD3, in LA157, R1═R2=CD2CD3, in LA158, R1═R2=CD(CH3)2, in LA159, R1=CD3, R2=CD2CD3, in LA160, R1=CD3, R2=CD(CH3)2, in LA161, R1=CD2CD3, R2=CD(CH3)2, in LA162, R1=CD3, R2=Ph, in LA163, R1=CD2CD3, R2=Ph, and in LA164, R1=CD3, R2=CD2CF3,
LA171 through LA190 having the structure
wherein in LA171, R1═R2=Me, in LA172, R1═R2=Et, in LA173, R1═R2=iPr, in LA174, R1=Me, R2=Et, in LA175, R1=Me, R2=iPr, in LA176, R1=Et, R2=iPr, in LA177, R1=Me, R2=Ph, in LA178, R1=Et, R2=Ph, in LA179, R1═R2=Ph, in LA180, R1═R2═F, in LA181, R1=Me, R2═CH2CF3, in LA182, R1═R2=CD3, in LA183, R1═R2=CD2CD3, in LA184, R1═R2=CD(CH3)2, in LA185, R1=CD3, R2=CD2CD3, in LA186, R1=CD3, R2=CD(CH3)2, in LA187, R1=CD2CD3, R2=CD(CH3)2, in LA188, R1=CD3, R2=Ph, in LA189, R1=CD2CD3, R2=Ph, and in LA190, R1=CD3, R2=CD2CF3,
LA197 through LA216 having the structure
wherein in LA197, R1═R2=Me, in LA198, R1═R2=Et, in LA199, R1═R2=iPr, in LA200, R1=Me, R2=Et, in LA201, R1=Me, R2=iPr, in LA202, R1=Et, R2=iPr, in LA203, R1=Me, R2=Ph, in LA204, R1=Et, R2=Ph, in LA205, R1═R2=Ph, in LA206, R1═R2═F, in LA207, R1=Me, R2═CH2CF3, in LA208, 10═R2=CD3, in LA209, R1═R2=CD2CD3, in LA210, R1═R2=CD(CH3)2, in LA211, R1=CD3, R2=CD2CD3, in LA212, R1=CD3, R2=CD(CH3)2, in LA213, R1=CD2CD3, R2=CD(CH3)2, in LA214, R1=CD3, R2=Ph, in LA215, R1=CD2CD3, R2=Ph, and in LA216, R1=CD3, R2=CD2CF3,
LA221 through LA240 having the structure
wherein in LA221, R1═R2=Me, in LA222, R1═R2=Et, in LA223, R1═R2=iPr, in LA224, R1=Me, R2=Et, in LA225, R1=Me, R2=iPr, in LA226, R1=Et, R2=iPr, in LA227, R1=Me, R2=Ph, in LA228, R1=Et, R2=Ph, in LA229, R1═R2=Ph, in LA230, R1═R2═F, in LA231, R1=Me, R2═CH2CF3, in LA232, R1═R2=CD3, in LA233, R1═R2=CD2CD3, in LA234, R1=R2CD(CH3)2, in LA235, R1=CD3, R2=CD2CD3, in LA236, R1=CD3, R2=CD(CH3)2, in LA237, R1=CD2CD3, R2=CD(CH3)2, in LA238, R1=CD3, R2=Ph, in LA239, R1=CD2CD3, R2=Ph, and in LA240, R1=CD3, R2=CD2CF3,
LA247 through LA266 having the structure
wherein in LA247, R1═R2=Me, in LA248, R1═R2=Et, in LA249, R1═R2=iPr, in LA250, R1=Me, R2=Et, in LA251, R1=Me, R2=iPr, in LA252, R1=Et, R2=iPr, in LA253, R1=Me, R2=Ph, in LA254, R1=Et, R2=Ph, in LA255, R1═R2=Ph, in LA256, R1═R2═F, in LA257, R1=Me, R2═CH2CF3, in LA258, R1═R2=CD3, in LA259, R1═R2=CD2CD3, in LA260, R1═R2=CD(CH3)2, in LA261, R1=CD3, R2=CD2CD3, in LA262, R1=CD3, R2=CD(CH3)2, in LA263, R1=CD2CD3, R2=CD(CH3)2, in LA264, R1=CD3, R2=Ph, in LA265, R1=CD2CD3, R2=Ph, and in LA266, R1=CD3, R2=CD2CF3,
LA273 through LA292 having the structure
wherein in LA273, R1═R2=Me, in LA274, R1═R2=Et, in LA275, R1═R2=iPr, in LA276, R1=Me, R2=Et, in LA277, R1=Me, R2=iPr, in LA278, R1=Et, R2=iPr, in LA279, R1=Me, R2=Ph, in LA280, R1=Et, R2=Ph, in LA281, R1═R2=Ph, in LA282, R1═R2═F, in LA283, R1=Me, R2═CH2CF3, in LA284, R1═R2=CD3, in LA285, R1═R2=CD2CD3, in LA286, R1═R2=CD(CH3)2, in LA287, R1=CD3, R2=CD2CD3, in LA288, R1=CD3, R2=CD(CH3)2, in LA289, R1=CD2CD3, R2=CD(CH3)2, in LA290, R1=CD3, R2=Ph, in LA291, R1=CD2CD3, R2=Ph, and in LA292, R1=CD3, R2-CD2CF3,
LA299 through LA318 having the structure
wherein in LA299, R1═R2=Me, in LA300, R1═R2=Et, in LA301, R1═R2=iPr, in LA302, R1=Me, R2=Et, in LA303, R1=Me, R2=iPr, in LA304, R1=Et, R2=iPr, in LA305, R1=Me, R2=Ph, in LA306, R1=Et, R2=Ph, in LA307, R1═R2=Ph, in LA308, R1═R2═F, in LA309, R1=Me, R2═CH2CF3, in LA310, R1═R2=CD3, in LA311, R1═R2=CD2CD3, in LA312, R1═R2=CD(CH3)2, in LA313, R1=CD3, R2=CD2CD3, in LA314, R1=CD3, R2-CD(CH3)2, in LA315, R1=CD2CD3, R2=CD(CH3)2, in LA316, R1=CD3, R2=Ph, in LA317, R1=CD2CD3, R2=Ph, and in LA318, R1=CD3, R2=CD2CF3,
LA325 through LA344 having the structure
wherein in LA325, R1═R2=Me, in LA326, R1═R2=Et, in LA327, R1═R2=iPr, in LA328, R1=Me, R2=Et, in LA329, R1=Me, R2=iPr, in LA330, R1=Et, R2=iPr, in LA331, R1=Me, R2=Ph, in LA332, R1=Et, R2=Ph, in LA333, R1═R2=Ph, in LA334, R1═R2═F, in LA335, R1=Me, R2═CH2CF3, in LA336, R1═R2=CD3, in LA337, R1═R2=CD2CD3, in LA338, R1═R2=CD(CH3)2, in LA339, R1=CD3, R2=CD2CD3, in LA340, R1=CD3, R2=CD(CH3)2, in LA341, R1=CD2CD3, R2=CD(CH3)2, in LA342, R1=CD3, R2=Ph, in LA343, R1=CD2CD3, R2=Ph, and in LA344, R1=CD3, R2=CD2CF3,
LA351 through LA370 having the structure
wherein in LA351, R1═R2=Me, in LA352, R1═R2=Et, in LA353, R1═R2=iPr, in LA354, R1=Me, R2=Et, in LA355, R1=Me, R2=iPr, in LA356, R1=Et, R2=iPr, in LA357, R1=Me, R2=Ph, in LA358, R1=Et, R2=Ph, in LA359, R1═R2=Ph, in LA360, R1═R2═F, in LA361, R1=Me, R2═CH2CF3, in LA362, R1═R2=CD3, in LA363, R1═R2=CD2CD3, in LA364, R1═R2=CD(CH3)2, in LA365, R1=CD3, R2=CD2CD3, in LA366, R1=CD3, R2=CD(CH3)2, in LA367, R1=CD2CD3, R2=CD(CH3)2, in LA368, R1=CD3, R2=Ph, in LA369, R1=CD2CD3, R2=Ph, and in LA370, R1=CD3, R2=CD2CF3,
LA371 through LA390 having the structure
wherein in LA371, R1═R2=Me, in LA372, R1═R2=Et, in LA373, R1═R2=iPr, in LA374, R1=Me, R2=Et, in LA375, R1=Me, R2=iPr, in LA376, R1=Et, R2=iPr, in LA377, R1=Me, R2=Ph, in LA378, R1=Et, R2=Ph, in LA379, R1═R2=Ph, in LA380, R1═R2═F, in LA381, R1=Me, R2═CH2CF3, in LA382, R1═R2=CD3, in LA383, R1═R2=CD2CD3, in LA384, R1═R2=CD(CH3)2, in LA385, R1=CD3, R2-CD2CD3, in LA386, R1=CD3, R2=CD(CH3)2, in LA387, R1=CD2CD3, R2=CD(CH3)2, in LA388, R1=CD3, R2=Ph, in LA389, R1=CD2CD3, R2=Ph, and in LA390, R1=CD3, R2=CD2CF3,
LA397 through LA416 having the structure
wherein in LA397, R1═R2=Me, in LA398, R1═R2=Et, in LA399, R1═R2=iPr, in LA400, R1=Me, R2=Et, in LA401, R1=Me, R2=iPr, in LA402, R1=Et, R2=iPr, in LA403, R1=Me, R2=Ph, in LA404, R1=Et, R2=Ph, in LA405, R1═R2=Ph, in LA406, R1═R2═F, in LA407, R1=Me, R2═CH2CF3, in LA408, R1═R2=CD3, in LA409, R1═R2=CD2CD3, in LA410, R1═R2=CD(CH3)2, in LA411, R1=CD3, R2=CD2CD3, in LA412, R1=CD3, R2=CD(CH3)2, in LA413, R1=CD2CD3, R2=CD(CH3)2, in LA414, R1=CD3, R2=Ph, in LA415, R1=CD2CD3, R2=Ph, and in LA416, R1=CD3, R2=CD2CF3,
LA423 through LA442 having the structure
wherein in LA423, R1═R2=Me, in LA424, R1═R2=Et, in LA425, R1═R2=iPr, in LA426, R1=Me, R2=Et, in LA427, R1=Me, R2=iPr, in LA428, R1=Et, R2=iPr, in LA429, R1=Me, R2=Ph, in LA430, R1=Et, R2=Ph, in LA431, R1═R2=Ph, in LA432, R1═R2═F, in LA433, R1=Me, R2═CH2CF3, in LA434, R1═R2-CD3, in LA435, R1═R2=CD2CD3, in LA436, R1═R2=CD(CH3)2, in LA437, R1=CD3, R2=CD2CD3, in LA438, R1=CD3, R2=CD(CH3)2, in LA439, R1=CD2CD3, R2=CD(CH3)2, in LA440, R1=CD3, R2=Ph, in LA441, R1=CD2CD3, R2=Ph, and in LA442, R1=CD3, R2=CD2CF3,
LA449 through LA468 having the structure
wherein in LA449, R1═R2=Me, in LA450, R1═R2=Et, in LA451, R1═R2=iPr, in LA452, R1=Me, R2=Et, in LA453, R1=m, R2=iPr, in LA454, R1=Et, me-R2=iPr, in LA455, R1=Me, R2=Ph, in LA456, R1=Et, R2=Ph, in LA457, R1═R2=Ph, in LA458, R1═R2═F, in LA459, R1=Me, R2═CH2CF3, in LA460, R1═R2=CD3, in LA461, R1═R2=CD2CD3, in LA462, R1═R2=CD(CH3)2, in LA463, R1=CD3, R2=CD2CD3, in LA464, R1=CD3, R2=CD(CH3)2, in LA465, R1=CD2CD3, R2=CD(CH3)2, in LA466, R1=CD3, R2=Ph, in LA467, R1=CD2CD3, R2=Ph, and in LA468, R1=CD3, R2=CD2CF3,
LA475 through LA494 having the structure
wherein in LA475, R1═R2=Me, in LA476, R1═R2=Et, in LA477, R1═R2=iPr, in LA478, R1=Me, R2=Et, in LA479, R1=Me, R2=iPr, in LA480, R1=Et, R2=iPr, in LA481, R1=Me, R2=Ph, in LA482, R1=Et, R2=Ph, in LA483, R1═R2=Ph, in LA484, R1═R2═F, in LA485, R1=Me, R2═CH2CF3, in LA486, R1═R2=CD3, in LA487, R1═R2=CD2CD3, in LA488, R1═R2=CD(CH3)2, in LA489, R1=CD3, R2=CD2CD3, in LA490, R1=CD3, R2=CD(CH3)2, in LA491, R1=CD2CD3, R2=CD(CH3)2, in LA492, R1=CD3, R2=Ph, in LA493, R1=CD2CD3, R2=Ph, and in LA494, R1=CD3, R2=CD2CF3,
LA501 through LA520 having the structure
wherein in LA501, R1═R2=Me, in LA502, R1═R2=Et, in LA503, R1═R2=iPr, in LA504, R1=Me, R2=Et, in LA505, R1=Me, R2=iPr, in LA506, R1=Et, R2=iPr, in LA507, R1=Me, R2=Ph, in LA508, R1=Et, R2=Ph, in LA509, R1═R2=Ph, in LA510, R1═R2═F, in LA511, R1=Me, R2═CH2CF3, in LA512, R1═R2=CD3, in LA513, R1═R2=CD2CD3, in LA514, R1═R2=CD(CH3)2, in LA515, R1=CD3, R2=CD2CD3, in LA516, R1=CD3, R2=CD(CH3)2, in LA517, R1=CD2CD3, R2=CD(CH3)2, in LA518, R1=CD3, R2=Ph, in LA519, R1=CD2CD3, R2=Ph, and in LA520, R1=CD3, R2=CD2CF3,
LA521 through LA540 having the structure
wherein in LA541, R1═R2=Me, in LA522, R1═R2=Et, in LA523, R1═R2=iPr, in LA524, R1=Me, R2=Et, in LA525, R1=Me, R2=iPr, in LA526, R1=Et, R2=iPr, in LA527, R1=Me, R2=Ph, in LA528, R1=Et, R2=Ph, in LA529, R1═R2=Ph, in LA530, R1═R2═F, in LA531, R1=Me, R2═CH2CF3, in LA532, R1═R2=CD3, in LA533, R1═R2=CD2CD3, in LA534, R1═R2=CD(CH3)2, in LA535, R1=CD3, R2=CD2CD3, in LA536, R1=CD3, R2=CD(CH3)2, in LA537, R1=CD2CD3, R2=CD(CH3)2, in LA538, R1=CD3, R2=Ph, in LA539, R1=CD2CD3, R2=Ph, and in LA540, R1=CD3, R2=CD2CF3,
LA547 through LA566 having the structure
wherein in LA547, R1═R2=Me, in LA548, R1═R2=Et, in LA549, R1═R2=iPr, in LA550, R1=Me, R2=Et, in LA551, R1=Me, R2=iPr, in LA552, R1=Et, R2=iPr, in LA553, R1=Me, R2=Ph, in LA554, R1=Et, R2=Ph, in LA555, R1═R2=Ph, in LA556, R1═R2═F, in LA557, R1=Me, R2═CH2CF3, in LA558, R1═R2=CD3, in LA550, R1═R2=CD2CD3, in LA560, R1═R2=CD(CH3)2, in LA561, R1=CD3, R2=CD2CD3, in LA562, R1=CD3, R2-CD(CH3)2, in LA563, R1=CD2CD3, R2=CD(CH3)2, in LA564, R1=CD3, R2=Ph, in LA565, R1=CD2CD3, R2=Ph, and in LA566, R1=CD3, R2-CD2CF3,
LA573 through LA592 having the structure
wherein in LA573, R1═R2=Me, in LA574, R1═R2=Et, in LA575, R1═R2=iPr, in LA576, R1=Me, R2=Et, in LA577, R1=Me, R2=iPr, in LA578, R1=Et, R2=iPr, in LA570, R1=Me, R2=Ph, in LA580, R1=Et, R2=Ph, in LA581, R1═R2=Ph, in LA582, R1═R2═F, in LA583, R1=Me, R2═CH2CF3, in LA584, R1═R2=CD3, in LA585, R1═R2=CD2CD3, in LA586, R1═R2=CD(CH3)2, in LA587, R1=CD3, R2=CD2CD3, in LA588, R1=CD3, R2-CD(CH3)2, in LA589, R1=CD2CD3, R2=CD(CH3)2, in LA590, R1=CD3, R2=Ph, in LA591, R1=CD2CD3, R2=Ph, and in LA592, R1=CD3, R2=CD2CF3,
LA599 through LA618 having the structure
wherein in LA599, R1═R2=Me, in LA600, R1═R2=Et, in LA601, R1═R2=iPr, in LA602, R1=Me, R2=Et, in LA603, R1=Me, R2=iPr, in LA604, R1=Et, R2=iPr, in LA605, R1=Me, R2=Ph, in LA606, R1=Et, R2=Ph, in LA607, R1═R2=Ph, in LA608, R1═R2═F, in LA609, R1=Me, R2═CH2CF3, in LA610, R1═R2=CD3, in LA611, R1═R2=CD2CD3, in LA612, R1═R2=CD(CH3)2, in LA613, R1=CD3, R2=CD2CD3, in LA614, R1=CD3, R2=CD(CH3)2, in LA615, R1=CD2CD3, R2=CD(CH3)2, in LA616, R1=CD3, R2=Ph, in LA617, R1=CD2CD3, R2=Ph, and in LA618, R1=CD3, R2=CD2CF3,
LA625 through LA644 having the structure
wherein in LA625, R1═R2=Me, in LA626, R1═R2=Et, in LA627, R1═R2=iPr, in LA628, R1=Me, R2=Et, in LA629, R1=Me, R2=iPr, in LA630, R1=Et, R2=iPr, in LA631, R1=Me, R2=Ph, in LA632, R1=Et, R2=Ph, in LA633, R1═R2=Ph, in LA634, R1═R2═F, in LA635, R1=Me, R2═CH2CF3, in LA636, R1═R2=CD3, in LA637, R1═R2=CD2CD3, in LA638, R1═R2=CD(CH3)2, in LA639, R1=CD3, R2=CD2CD3, in LA640, R1=CD3, R2=CD(CH3)2, in LA641, R1=CD2CD3, R2=CD(CH3)2, in LA642, R1=CD3, R2=Ph, in LA643, R1=CD2CD3, R2=Ph, and in LA644, R1=CD3, R2=CD2CF3,
LA651 through LA670 having the structure
wherein in LA651, R1═R2=Me, in LA652, R1═R2=Et, in LA653, R1═R2=iPr, in LA654, R1=Me, R2=Et, in LA655, R1=Me, R2=iPr, in LA656, R1=Et, R2=iPr, in LA657, R1=Me, R2=Ph, in LA658, R1=Et, R2=Ph, in LA659, R1═R2=Ph, in LA660, R1═R2═F, in LA661, R1=Me, R2═CH2CF3, in LA662, R1═R2-CD3, in LA663, R1═R2=CD2CD3, in LA664, R1═R2=CD(CH3)2, in LA665, R1=CD3, R2-CD2CD3, in LA666, R1=CD3, R2=CD(CH3)2, in LA667, R1=CD2CD3, R2=CD(CH3)2, in LA668, R1=CD3, R2=Ph, in LA669, R1=CD2CD3, R2=Ph, and in LA670, R1=CD3, R2=CD2CF3,
LA671 through LA690 having the structure
wherein in LA671, R1═R2=Me, in LA672, R1═R2=Et, in LA673, R1═R2=iPr, in LA674, R1=Me, R2=Et, in LA675, R1=Me, R2=iPr, in LA676, R1=Et, R2=iPr, in LA677, R1=Me, R2=Ph, in LA678, R1=Et, R2=Ph, in LA679, R1═R2=Ph, in LA680, R1═R2═F, in LA681, R1=Me, R2═CH2CF3, in LA682, R1═R2-CD3, in LA683, R1═R2=CD2CD3, in LA684, R1═R2=CD(CH3)2, in LA685, R1=CD3, R2=CD2CD3, in LA686, R1=CD3, R2=CD(CH3)2, in LA687, R1=CD2CD3, R2=CD(CH3)2, in LA688, R1=CD3, R2=Ph, in LA689, R1=CD2CD3, R2=Ph, and in LA690, R1=CD3, R2=CD2CF3,
LA697 through LA716 having the structure
wherein in LA697, R1═R2=Me, in LA698, R1═R2=Et, in LA699, R1═R2=iPr, in LA700, R1=Me, R2=Et, in LA701, R1=Me, R2=iPr, in LA702, R1=Et, R2=iPr, in LA703, R1=Me, R2=Ph, in LA704, R1=Et, R2=Ph, in LA705, R1═R2=Ph, in LA706, R1═R2═F, in LA707, R1=Me, R2═CH2CF3, in LA708, R1═R2=CD3, in LA709, R1═R2=CD2CD3, in LA710, R1═R2=CD(CH3)2, in LA711, R1=CD3, R2=CD2CD3, in LA712, R1=CD3, R2=CD(CH3)2, in LA713, R1=CD2CD3, R2=CD(CH3)2, in LA714, R1=CD3, R2=Ph, in LA715, R1=CD2CD3, R2=Ph, and in LA716, R1=CD3, R2=CD2CF3,
LA723 through LA742 having the structure
wherein in LA723, R1═R2=Me, in LA724, R1═R2=Et, in LA725, R1═R2=iPr, in LA726, R1=Me, R2=Et, in LA727, R1=Me, R2=iPr, in LA728, R1=Et, R2=iPr, in LA729, R1=Me, R2=Ph, in LA730, R1=Et, R2=Ph, in LA731, R1═R2=Ph, in LA732, R1═R2═F, in LA733, R1=Me, R2═CH2CF3, in LA734, R1═R2=CD3, in LA735, R1═R2=CD2CD3, in LA736, R1═R2=CD(CH3)2, in LA737, R1=CD3, R2=CD2CD3, in LA738, R1=CD3, R2=CD(CH3)2, in LA739, R1=CD2CD3, R2=CD(CH3)2, in LA740, R1=CD3, R2=Ph, in LA741, R1=CD2CD3, R2=Ph, and in LA742, R1=CD3, R2=CD2CF3,
LA749 through LA768 having the structure
wherein in LA749, R1═R2=Me, in LA750, R1═R2=Et, in LA751, R1═R2=iPr, in LA752, R1=Me, R2=Et, in LA753, R1=Me, R2=iPr, in LA754, R1=Et, R2=iPr, in LA755, R1=Me, R2=Ph, in LA756, R1=Et, R2=Ph, in LA757, R1═R2=Ph, in LA758, R1═R2═F, in LA759, R1=Me, R2═CH2CF3, in LA760, R1═R2=CD3, in LA761, R1═R2=CD2CD3, in LA762, R1═R2=CD(CH3)2, in LA763, R1=CD3, R2=CD2CD3, in LA764, R1=CD3, R2=CD(CH3)2, in LA765, R1=CD2CD3, R2=CD(CH3)2, in LA766, R1=CD3, R2=Ph, in LA767, R1=CD2CD3, R2=Ph, and in LA768, R1=CD3, R2=CD2CF3,
LA775 through LA794 having the structure
wherein in LA775, R1═R2=Me, in LA776, R1═R2=Et, in LA777, R1═R2=iPr, in LA778, R1=Me, R2=Et, in LA779, R1=Me, R2=iPr, in LA780, R1=Et, R2=iPr, in LA781, R1=Me, R2=Ph, in LA782, R1=Et, R2=Ph, in LA783, R1═R2=Ph, in LA784, R1═R2═F, in LA785, R1=Me, R2═CH2CF3, in LA786, R1═R2=CD3, in LA787, R1═R2=CD2CD3, in LA788, R1═R2=CD(CH3)2, in LA789, R1=CD3, R2=CD2CD3, in LA790, R1=CD3, R2-CD(CH3)2, in LA791, R1=CD2CD3, R2=CD(CH3)2, in LA792, R1=CD3, R2=Ph, in LA793, R1=CD2CD3, R2=Ph, and in LA794, R1=CD3, R2=CD2CF3,
LA801 through LA820 having the structure
wherein in LA801, R1═R2=Me, in LA802, R1═R2=Et, in LA803, R1═R2=iPr, in LA804, R1=Me, R2=Et, in LA805, R1=Me, R2=iPr, in LA806, R1=Et, R2=iPr, in LA807, R1=Me, R2=Ph, in LA808, R1=Et, R2=Ph, in LA809, R1═R2=Ph, in LA810, R1═R2═F, in LA8n, R1=Me, R2═CH2CF3, in LA812, R1═R2=CD3, in LA813, R1═R2=CD2CD3, in LA814, R1═R2=CD(CH3)2, in LA815, R1=CD3, R2=CD2CD3, in LA816, R1=CD3, R2=CD(CH3)2, in LA817, R1=CD2CD3, R2=CD(CH3)2, in LA818, R1=CD3, R2=Ph, in LA819, R1=CD2CD3, R2=Ph, and in LA820, R1=CD3, R2-CD2CF3,
LA821 through LA840 having the structure
wherein in LA821, R1═R2=Me, in LA822, R1═R2=Et, in LA823, R1═R2=iPr, in LA824, R1=Me, R2=Et, in LA825, R1=Me, R2=iPr, in LA826, R1=Et, R2=iPr, in LA827, R1=Me, R2=Ph, in LA828, R1=Et, R2=Ph, in LA829, R1═R2=Ph, in LA830, R1═R2═F, in LA831, R1=Me, R2═CH2CF3, in LA832, R1═R2=CD3, in LA833, R1═R2=CD2CD3, in LA834, R1═R2=CD(CH3)2, in LA835, R1=CD3, R2=CD2CD3, in LA836, R1=CD3, R2=CD(CH3)2, in LA837, R1=CD2CD3, R2=CD(CH3)2, in LA838, R1=CD3, R2=Ph, in LA839, R1=CD2CD3, R2=Ph, and in LA840, R1=CD3, R2=CD2CF3,
LA846 through LA865 having the structure
wherein in LA846, R1═R2=Me, in LA847, R1═R2=Et, in LA848, R1═R2=iPr, in LA849, R1=Me, R2=Et, in LA850, R1=Me, R2=iPr, in LA851, R1=Et, R2=iPr, in LA852, R1=Me, R2=Ph, in LA853, R1=Et, R2=Ph, in LA854, R1═R2=Ph, in LA855, R1═R2═F, in LA856, R1=Me, R2═CH2CF3, in LA857, R1═R2=CD3, in LA858, R1═R2=CD2CD3, in LA859, R1═R2=CD(CH3)2, in LA860, R1=CD3, R2=CD2CD3, in LA861, R1=CD3, R2=CD(CH3)2, in LA862, R1=CD2CD3, R2=CD(CH3)2, in LA863, R1=CD3, R2=Ph, in LA864, R1=CD2CD3, R2=Ph, and in LA865, R1=CD3, R2=CD2CF3,
LA872 through LA891 having the structure
wherein in LA872, R1═R2=Me, in LA873, R1═R2=Et, in LA874, R1═R2=iPr, in LA875, R1=Me, R2=Et, in LA876, R1=Me, R2=iPr, in LA877, R1=Et, R2=iPr, in LA878, R1=Me, R2=Ph, in LA879, R1=Et, R2=Ph, in LA880, R1═R2=Ph, in LA881, R1═R2═F, in LA882, R1=Me, R2═CH2CF3, in LA883, R1═R2=CD3, in LA884, R1═R2=CD2CD3, in LA885, R1═R2=CD(CH3)2, in LA886, R1=CD3, R2=CD2CD3, in LA887, R1=CD3, R2=CD(CH3)2, in LA888, R1=CD2CD3, R2=CD(CH3)2, in LA889, R1=CD3, R2=Ph, in LA890, R1=CD2CD3, R2=Ph, and in LA891, R1=CD3, R2=CD2CF3,
LA898 through LA917 having the structure
wherein in LA898, R1═R2=Me, in LA899, R1═R2=Et, in LA900, R1═R2=iPr, in LA901, R1=Me, R2=Et, in LA902, R1=Me, R2=iPr, in LA903, R1=Et, R2=iPr, in LA904, R1=Me, R2=Ph, in LA905, R1=Et, R2=Ph, in LA906, R1═R2=Ph, in LA907, R1═R2═F, in LA908, R1=Me, R2═CH2CF3, in LA909, R1═R2=CD3, in LA910, R1═R2=CD2CD3, in LA911, R1═R2=CD(CH3)2, in LA912, R1=CD3, R2=CD2CD3, in LA913, R1=CD3, R2=CD(CH3)2, in LA914, R1=CD2CD3, R2=CD(CH3)2, in LA915, R1=CD3, R2=Ph, in LA916, R1=CD2CD3, R2=Ph, and in LA917, R1=CD3, R2=CD2CF3,
LA924 through LA943 having the structure
wherein in LA924, R1═R2=Me, in LA925, R1═R2=Et, in LA926, R1═R2=iPr, in LA927, R1=Me, R2=Et, in LA928, R1=Me, R2=iPr, in LA929, R1=Et, R2=iPr, in LA930, R1=Me, R2=Ph, in LA931, R1=Et, R2=Ph, in LA932, R1═R2=Ph in LA933, R1═R2═F, in LA934, R1=Me, R2═CH2CF3, in LA935, R1═R2=CD3, in LA936, R1═R2=CD2CD3, in LA937, R1═R2=CD(CH3)2, in LA938, R1=CD3, R2=CD2CD3, in LA939, R1=CD3, R2=CD(CH3)2, in LA940, R1=CD2CD3, R2=CD(CH3)2, in LA941, R1=CD3, R2=Ph, in LA942, R1=CD2CD3, R2=Ph, and in LA943, R1=CD3, R2=CD2CF3,
LA950 through LA969 having the structure
wherein in LA950, R1═R2=Me, in LA951, R1═R2=Et, in LA952, R1═R2=iPr, in LA953, R1=Me, R2=Et, in LA954, R1=Me, R2=iPr, in LA955, R1=Et, R2=iPr, in LA956, R1=Me, R2=Ph, in LA957, R1=Et, R2=Ph, in LA958, R1═R2=Ph, in LA959, R1═R2═F, in LA960, R1=Me, R2═CH2CF3, in LA961, R1═R2=CD3, in LA962, R1═R2=CD2CD3, in LA963, R1═R2=CD(CH3)2, in LA964, R1=CD3, R2=CD2CD3, in LA965, R1=CD3, R2=CD(CH3)2, in LA966, R1=CD2CD3, R2=CD(CH3)2, in LA967, R1=CD3, R2=Ph, in LA968, R1=CD2CD3, R2=Ph, and in LA969, R1=CD3, R2=CD2CF3,
LA970 through LA989 having the structure
wherein in LA970, R1═R2=Me, in LA971, R1═R2=Et, in LA972, R1=2=iPr, in LA973, R1=Me, R2=Et, in LA974, R1=Me, R2=iPr, in LA975, R1=Et, R2=iPr, in LA976, R1=Me, R2=Ph, in LA977, R1=Et, R2=Ph, in LA978, R1═R2=Ph, in LA979, R1═R2═F, in LA980, R1=Me, R2═CH2CF3, in LA981, R1═R2=CD3, in LA982, R1═R2=CD2CD3, in LA983, R1═R2=CD(CH3)2, in LA984, R1=CD3, R2=CD2CD3, in LA985, R1=CD3, R2=CD(CH3)2, in LA986, R1=CD2CD3, R2=CD(CH3)2, in LA987, R1=CD3, R2=Ph, in LA988, R1=CD2CD3, R2=Ph, and in LA989, R1=CD3, R2=CD2CF3,
LA996 through LA1015 having the structure
wherein in LA996, R1═R2=Me, in LA997, R1═R2=Et, in LA998, R1═R2=iPr, in LA999, R1=Me, R2=Et, in LA1000, R1=Me, R2=iPr, in LA1001, R1=Et, R2=iPr, in LA1002, R1=Me, R2=Ph, in LA1003, R1=Et, R2=Ph, in LA1004, R1═R2=Ph, in LA1005, R1═R2═F, in LA1006, R1=Me, R2═CH2CF3, in LA1007, R1═R2=CD3, in LA1008, R1═R2=CD2CD3, in LA1009, R1═R2=CD(CH3)2, in LA1010, R1=CD3, R2=CD2CD3, in LA1011, R1=CD3, R2=CD(CH3)2, in LA1012, R1=CD2CD3, R2=CD(CH3)2, in LA1013, R1=CD3, R2=Ph, in LA1014, R1=CD2CD3, R2=Ph, and in LA1015, R1=CD3, R2=CD2CF3,
LA1022 through LA1041 having the structure
wherein in LA1022, R1═R2=Me, in LA1023, R1═R2=Et, in LA1024, R1═R2=iPr, in LA1025, R1=Me, R2=Et, in LA1026, R1=Me, R2=iPr, in LA1027, R1=Et, R2=iPr, in LA1028, R1=Me, R2=Ph, in LA1029, R1=Et, R2=Ph, in LA1030, R1═R2=Ph, in LA1031, R1═R2═F, in LA1032, R1=Me, R2═CH2CF3, in LA1033, R1═R2=CD3, in LA1034, R1═R2=CD2CD3, in LA1035, R1═R2=CD(CH3)2, in LA1036, R1=CD3, R2=CD2CD3, in LA1037, R1=CD3, R2-CD(CH3)2, in LA1038, R1=CD2CD3, R2=CD(CH3)2, in LA1039, R1=CD3, R2=Ph, in LA1040, R1=CD2CD3, R2=Ph, and in LA1041, R1=CD3, R2=CD2CF3,
LA1048 through LA1067 having the structure
wherein in LA1048, R1═R2=Me, in LA1049, R1═R2=Et, in LA1050, R1═R2=iPr, in LA1051, R1=Me, R2=Et, in LA1052, R1=Me, R2=iPr, in LA1053, R1=Et, R2=iPr, in LA1054, R1=Me, R2=Ph, in LA1055, R1=Et, R2=Ph, in LA1056, R1═R2=Ph, in LA1057, R1═R2═F, in LA1058, R1=Me, R2═CH2CF3, in LA1059, R1═R2=CD3, in LA1060, R1═R2=CD2CD3, in LA1061, R1═R2=CD(CH3)2, in LA1062, R1=CD3, R2=CD2CD3, in LA1063, R1=CD3, R2-CD(CH3)2, in LA1064, R1=CD2CD3, R2=CD(CH3)2, in LA1065, R1=CD3, R2=Ph, in LA1066, R1=CD2CD3, R2=Ph, and in LA1067, R1=CD3, R2=CD2CF3,
LA1074 through LA1093 having the structure
wherein in LA1074, R1═R2=Me, in LA1375, R1═R2=Et, in LA1076, R1═R2=iPr, in LA1077, R1=Me, R2=Et, in LA1078, R1=Me, R2=iPr, in LA1079, R1=Et, R2=iPr, in LA1080, R1=Me, R2=Ph, in LA1081, R1=Et, R2=Ph, in LA1o82, R1═R2=Ph, in LA1083, R1═R2═F, in LA1084, R1=Me, R2═CH2CF3, in LA1085, R1═R2=CD3, in LA1086, R1═R2=CD2CD3, in LA1087, R1═R2=CD(CH3)2, in LA1088, R1=CD3, R2=CD2CD3, in LA1089, R1=CD3, R2=CD(CH3)2, in LA1090, R1=CD2CD3, R2=CD(CH3)2, in LA1091, R1=CD3, R2=Ph, in LA1092, R1=CD2CD3, R2=Ph, and in LA1093, R1=CD3, R2=CD2CF3,
LA1100 through LA1119 having the structure
wherein in LA1100, R1═R2=Me, in LA1101, R1═R2=Et, in LA1102, R1═R2=iPr, in LA1103, R1=Me, R2=Et, in LA1104, R1=Me, R2=iPr, in LA1105, R1=Et, R2=iPr, in LA1106, R1=Me, R2=Ph, in LA1107, R1=Et, R2=Ph, in LA1108, R1═R2=Ph, in LA1109, R1═R2═F, in LA1110, R1=Me, R2═CH2CF3, in LA1111, R1═R2=CD3, in LA1112, R1═R2=CD2CD3, in LA1113, R1═R2=CD(CH3)2, in LA1114, R1=CD3, R2=CD2CD3, in LA1115, R1=CD3, R2=CD(CH3)2, in LA1116, R1=CD2CD3, R2=CD(CH3)2, in LA1117, R1=CD3, R2=Ph, in LA1118, R1=CD2CD3, R2=Ph, and in LA1119, R1=CD3, R2=CD2CF3,
LA1120 through LA1139 having the structure
wherein in LA1120, R1═R2=Me, in LA1121, R1═R2=Et, in LA1122, R1═R2=iPr, in LA1123, R1=Me, R2=Et, in LA1124, R1=Me, R2=iPr, in LA1125, R1=Et, R2=iPr, in LA1126, R1=Me, R2=Ph, in LA1127, R1=Et, R2=Ph, in LA1128, R1═R2=Ph, in LA1129, R1═R2═F, in LA1130, R1=Me, R2═CH2CF3, in LA1131, R1═R2=CD3, in LA1132, R1═R2=CD2CD3, in LA1133, R1═R2=CD(CH3)2, in LA1134, R1=CD3, R2=CD2CD3, in LA1135, R1=CD3, R2=CD(CH3)2, in LA1136, R1=CD2CD3, R2=CD(CH3)2, in LA1137, R1=CD3, R2=Ph, in LA1138, R1=CD2CD3, R2=Ph, and in LA1139, R1=CD3, R2=CD2CF3,
LA1146 through LA1165 having the structure
wherein in LA1146, R1═R2=Me, in LA1147, R1═R2=Et, in LA1148, R1═R2=iPr, in LA1149, R1=Me, R2=Et, in LA1150, R1=Me, R2=iPr, in LA1151, R1=Et, R2=iPr, in LA1152, R1=Me, R2=Ph, in LA1153, R1=Et, R2=Ph, in LA1154, R1═R2=Ph, in LA1155, R1═R2═F, in LA1156, R1=Me, R2═CH2CF3, in LA1157, R1═R2=CD3, in LA1158, R1═R2=CD2CD3, in LA1159, R1═R2=CD(CH3)2, in LA1160, R1=CD3, R2=CD2CD3, in LA1161, R1=CD3, R2=CD(CH3)2, in LA1162, R1=CD2CD3, R2=CD(CH3)2, in LA1163, R1=CD3, R2=Ph, in LA1164, R1=CD2CD3, R2=Ph, and in LA1165, R1=CD3, R2=CD2CF3,
LA1172 through LA1191 having the structure
wherein in LA1172, R1═R2=Me, in LA1173, R1═R2=Et, in LA1174, R1═R2=iPr, in LA1175, R1=Me, R2=Et, in LA1176, R1=Me, R2=iPr, in LA1177, R1=Et, R2=iPr, in LA1178, R1=Me, R2=Ph, in LA1179, R1=Et, R2=Ph, in LA1180, R1═R2=Ph, in LA1181, R1═R2═F, in LA1182, R1=Me, R2═CH2CF3, in LA1183, R1═R2=CD3, in LA1184, R1═R2=CD2CD3, in LA1185, R1═R2=CD(CH3)2, in LA1186, R1=CD3, R2=CD2CD3, in LA1187, R1=CD3, R2=CD(CH3)2, in LA1188, R1=CD2CD3, R2=CD(CH3)2, in LA1189, R1=CD3, R2=Ph, in LA1190, R1=CD2CD3, R2=Ph, and in LA1191, R1=CD3, R2=CD2CF3,
LA1198 through LA1217 having the structure
wherein in LA1198, R1═R2=Me, in LA1199, R1═R2=Et, in LA1200, R1═R2=iPr, in LA1201, R1=Me, R2=Et, in LA1202, R1=Me, R2=iPr, in LA1203, R1=Et, R2=iPr, in LA1204, R1=Me, R2=Ph, in LA1205, R1=Et, R2=Ph, in LA1206, R1═R2=Ph, in LA1207, R1═R2═F, in LA1208, R1=Me, R2═CH2CF3, in LA1209, R1═R2=CD3, in LA1210, R1═R2=CD2CD3, in LA1211, R1═R2=CD(CH3)2, in LA1212, R1=CD3, R2=CD2CD3, in LA1213, R1=CD3, R2=CD(CH3)2, in LA1214, R1=CD2CD3, R2=CD(CH3)2, in LA1215, R1=CD3, R2=Ph, in LA1216, R1=CD2CD3, R2=Ph, and in LA1217, R1=CD3, R2=CD2CF3,
LA1224 through LA1243 having the structure
wherein in LA1224, R1═R2=Me, in LA1225, R1═R2=Et, in LA1226, R1═R2=iPr, in LA1227, R1=Me, R2=Et, in LA1228, R1=Me, R2=iPr, in LA1229, R1=Et, R2=iPr, in LA1230, R1=Me, R2=Ph, in LA1231, R1=Et, R2=Ph, in LA1232, R1═R2=Ph, in LA1233, R1═R2═F, in LA1234, R1=Me, R2═CH2CF3, in LA1235, R1═R2=CD3, in LA1236, R1═R2=CD2CD3, in LA1237, R1═R2=CD(CH3)2, in LA1238, R1=CD3, R2=CD2CD3, in LA1239, R1=CD3, R2=CD(CH3)2, in LA1240, R1=CD2CD3, R2=CD(CH3)2, in LA1241, R1=CD3, R2=Ph, in LA1242, R1=CD2CD3, R2=Ph, and in LA1243, R1=CD3, R2=CD2CF3,
LA1250 through LA1269 having the structure
wherein in LA1250, R1═R2=Me, in LA1251, R1═R2=Et, in LA1252, R1═R2=iPr, in LA1253, R1=Me, R2=Et, in LA1254, R1=Me, R2=iPr, in LA1255, R1=Et, R2=iPr, in LA1256, R1=Me, R2=Ph, in LA1257, R1=Et, R2=Ph, in LA1258, R1═R2=Ph, in LA1259, R1═R2═F, in LA1260, R1=Me, R2═CH2CF3, in LA1261, R1═R2=CD3, in LA1262, R1═R2=CD2CD3, in LA1263, R1═R2=CD(CH3)2, in LA1264, R1=CD3, R2=CD2CD3, in LA1265, R1=CD3, R2=CD(CH3)2, in LA1266, R1=CD2CD3, R2=CD(CH3)2, in LA1267, R1=CD3, R2=Ph, in LA1268, R1=CD2CD3, R2=Ph, and in LA1269, R1=CD3, R2=CD2CF3,
LA1270 through LA1289 having the structure
wherein in LA1270, R1═R2=Me, in LA1271, R1═R2=Et, in LA1272, R1═R2=iPr, in LA1273, R1=Me, R2=Et, in LA1274, R1=Me, R2=iPr, in LA1275, R1=Et, R2=iPr, in LA1276, R1=Me, R2=Ph, in LA1277, R1=Et, R2=Ph, in LA1278, R1═R2=Ph, in LA1279, R1═R2═F, in LA1280, R1=Me, R2═CH2CF3, in LA1281, R1═R2=CD3, in LA1282, R1═R2=CD2CD3, in LA1283, R1═R2=CD(CH3)2, in LA1284, R1=CD3, R2=CD2CD3, in LA1285, R1=CD3, R2=CD(CH3)2, in LA1286, R1=CD2CD3, R2=CD(CH3)2, in LA1287, R1=CD3, R2=Ph, in LA1288, R1=CD2CD3, R2=Ph, and in LA1289, R1=CD3, R2=CD2CF3,
LA1296 through LA1315 having the structure
wherein in LA1296, R1═R2=Me, in LA1297, R1═R2=Et, in LA1298, R1═R2=iPr, in LA1299, R1=Me, R2=Et, in LA1300, R1=Me, R2=iPr, in LA1301, R1=Et, R2=iPr, in LA1302, R1=Me, R2=Ph, in LA1303, R1=Et, R2=Ph, in LA1304, R1═R2=Ph, in LA1305, R1═R2═F, in LA1306, R1=Me, R2═CH2CF3, in LA1307, R1═R2=CD3, in LA1308, R1═R2=CD2CD3, in LA1309, R1═R2=CD(CH3)2, in LA1310, R1=CD3, R2=CD2CD3, in LA1311, R1=CD3, R2=CD(CH3)2, in LA1312, R1=CD2CD3, R2=CD(CH3)2, in LA1313, R1=CD3, R2=Ph, in LA1314, R1=CD2CD3, R2=Ph, and in LA1315, R1=CD3, R2=CD2CF3,
LA1322 through LA1341 having the structure
wherein in LA1322, R1═R2=Me, in LA1323, R1═R2=Et, in LA1324, R1═R2=iPr, in LA1325, R1=Me, R2=Et, in LA1326, R2=iPr, in LA1327, R1=Et, R2=iPr, in LA1328, R1=Me, R2=Ph, in LA1329, R2=Ph, in LA1330, R1═R2=Ph, in LA1331, R1═R2═F, in LA1332, R1=Me, R2═CH2CF3, in LA1333, R1═R2=CD3, in LA1334, R1═R2=CD2CD3, in LA1335, R1═R2=CD(CH3)2, in LA1336, R1=CD3, R2=CD2CD3, in LA1337, R1=CD3, R2=CD(CH3)2, in LA1338, R1=CD2CD3, R2=CD(CH3)2, in LA1339, R1=CD3, R2=Ph, in LA1340, R1=CD2CD3, R2=Ph, and in LA1341, R1=CD3, R2=CD2CF3,
LA1348 through LA1367 having the structure
wherein in LA1348, R1═R2=Me, in LA1349, R1═R2=Et, in LA1350, R1═R2=iPr, in LA1351, R1=Me, in LA1352, R1=Me, R2=iPr, in LA1353, R1=Et, R2=iPr, in LA1354, R1=Me, R2=Ph, in LA1355, R1=Et, R2=Ph, in LA1356, R1═R2=Ph, in LA1357, R1═R2═F, in LA1358, R1=Me, R2═CH2CF3, in LA1359, R1═R2=CD3, in LA1360, R1═R2=CD2CD3, in LA1361, R1═R2=CD(CH3)2, in LA1362, R1=CD3, R2=CD2CD3, in LA1363, R1=CD3, R2=CD(CH3)2, in LA1364, R1=CD2CD3, R2=CD(CH3)2, in LA1365, R1=CD3, R2=Ph, in LA1366, R1=CD2CD3, R2=Ph, and in LA1367, R1=CD3, R2=CD2CF3,
LA1374 through LA1393 having the structure
wherein in LA1374, R1═R2=Me, in LA1375, R1═R2=Et, in LA1376, R1═R2=iPr, in LA1377, R1=Me, R2=Et, in LA1378, R1=Me, R2=iPr, in LA1379, R1=Et, R2=iPr, in LA1380, R1=Me, R2=Ph, in LA1381, R1=Et, R2=Ph, in LA1382, R1═R2=Ph, in LA1383, R1═R2═F, in LA1384, R1=Me, R2═CH2CF3, in LA1385, R1═R2=CD3, in LA1386, R1═R2=CD2CD3, in LA1387, R1═R2=CD(CH3)2, in LA1388, R1=CD3, R2=CD2CD3, in LA1389, R1=CD3, R2=CD(CH3)2, in LA1390, R1=CD2CD3, R2=CD(CH3)2, in LA1391, R1=CD3, R2=Ph, in LA1392, R1=CD2CD3, R2=Ph, and in LA1393, R1=CD3, R2=CD2CF3,
LA1400 through LA1419 having the structure
wherein in LA1400, R1═R2=Me, in LA1401, R1═R2=Et, in LA1402, R1═R2=iPr, in LA1403, R1=Me, R2=Et, in LA14o4, R1=Me, R2=iPr, in LA1405, R1=Et, R2=iPr, in LA1406, R1=Me, R2=Ph, in LA1407, R1=Et, R2=Ph, in LA1408, R1═R2=Ph, in LA1409, R1═R2═F, in LA1410, R1=Me, R2═CH2CF3, in LA1411, R1═R2=CD3, in LA1412, R1═R2=CD2CD3, in LA1413, R1═R2=CD(CH3)2, in LA1414, R1=CD3, R2=CD2CD3, in LA1415, R1=CD3, R2=CD(CH3)2, in LA1416, R1=CD2CD3, R2=CD(CH3)2, in LA1417, R1=CD3, R2=Ph, in LA1418, R1=CD2CD3, R2=Ph, and in LA1419, R1=CD3, R2=CD2CF3,
LA1420 through LA1439 having the structure
wherein in LA1420, R1═R2=Me, in LA1421, R1═R2=Et, in LA1422, R1═R2=iPr, in LA1423, R1=Me, R2=Et, in LA1424, R1=Me, R2=iPr, in LA1425, R1=Et, R2=iPr, in LA1426, R1=Me, R2=Ph, in LA1427, R1=Et, R2=Ph, in LA1428, R1═R2=Ph, in LA1429, R1═R2═F, in LA1430, R1=Me, R2═CH2CF3, in LA1431, R1═R2=CD3, in LA1432, R1═R2=CD2CD3, in LA1433, R1═R2=CD(CH3)2, in LA1434, R1=CD3, R2=CD2CD3, in LA1435, R1=CD3, R2=CD(CH3)2, in LA1436, R1=CD2CD3, R2=CD(CH3)2, in LA1437, R1=CD3, R2=Ph, in LA1438, R1=CD2CD3, R2=Ph, and in LA1439, R1=CD3, R2=CD2CF3,
LA1446 through LA1465 having the structure
wherein in LA1446, R1═R2=Me, in LA1447, R1═R2=Et, in LA1448, R1═R2=iPr, in LA1449, R1=Me, R2=Et, in LA1450, R1=Me, R2=iPr, in LA1451, R1=Et, R2=iPr, in LA1452, R1=Me, R2=Ph, in LA1453, R1=Et, R2=Ph, in LA1454, R1═R2=Ph, in LA1455, R1═R2═F, in LA1456, R1=Me, R2═CH2CF3, in LA1457, R1═R2=CD3, in LA1458, R1═R2=CD2CD3, in LA1459, R1═R2=CD(CH3)2, in LA1460, R1=CD3, R2=CD2CD3, in LA1461, R1=CD3, R2=CD(CH3)2, in LA1462, R1=CD2CD3, R2=CD(CH3)2, in LA1463, R1=CD3, R2=Ph, in LA1464, R1=CD2CD3, R2=Ph, and in LA1465, R1=CD3, R2=CD2CF3,
LA1472 through LA1491 having the structure
wherein in LA1472, R1═R2=Me, in LA1473, R2=iPr, in LA1477, R1=Et, R1═R2=Et, in LA1474, R1═R2=iPr, in LA1475, R1=Me, R2=Et, in LA1476, R1=Me, R2=iPr, in LA1478, R1=Me, R2=Ph, in LA1479, R1=Et, R2=Ph, in LA1480, R1═R2=Ph, in LA1481, R1═R2═F, in LA1482, R1=Me, R2═CH2CF3, in LA1483, R1═R2=CD3, in LA1484, R1═R2=CD2CD3, in LA1485, R1═R2=CD(CH3)2, in LA1486, R1=CD3, R2=CD2CD3, in LA1487, R1=CD3, R2-CD(CH3)2, in LA1488, R1=CD2CD3, R2=CD(CH3)2, in LA1489, R1=CD3, R2=Ph, in LA1490, R1=CD2CD3, R2=Ph, and in LA1491, R1=CD3, R2=CD2CF3,
LA1498 through LA1516 having the structure
wherein in LA1498, R1═R2=Me, in LA1499, R1═R2=Et, in LA1500, R1═R2=iPr, in LA1501, R1=Me, R2=Et, in LA1502, R1=Me, R2=iPr, in LA1503, R1=Et, R2=iPr, in LA1504, R1=Me, R2=Ph, in LA1505, R1=Et, R2=Ph, in LA1506, R1═R2=Ph, in LA1507, R1═R2═F, in LA1508, R1=Me, R2═CH2CF3, in LA1509, R1═R2=CD3, in LA1510, R1═R2=CD2CD3, in LA1511, R1═R2=CD(CH3)2, in LA1512, R1=CD3, R2=CD2CD3, in LA1513, R1=CD3, R2=CD(CH3)2, in LA1514, R1=CD2CD3, R2=CD(CH3)2, in LA1515, R1=CD3, R2=Ph, and in LA1516, R1=CD2CD3, R2=Ph,
LA1523 through LA1542 having the structure
wherein in LA1523, R1═R2=Me, in LA1524, R1═R2=Et, in LA1525, R1═R2=iPr, in LA1526, R1=Me, R2=Et, in LA1527, R1=Me, R2=iPr, in LA1528, R1=Et, R2=iPr, in LA1529, R1=Me, R2=Ph, in LA1530, R2=Ph, in LA1531, R1═R2=Ph, in LA1532, R1═R2═F, in LA1533, R1=Me, R2═CH2CF3, in LA1534, R1═R2=CD3, in LA1535, R1═R2=CD2CD3, in LA1536, R1═R2=CD(CH3)2, in LA1537, R1=CD3, R2=CD2CD3, in LA1538, R1=CD3, R2=CD(CH3)2, in LA1539, R1=CD2CD3, R2=CD(CH3)2, in LA1540, R1=CD3, R2=Ph, in LA1541, R1=CD2CD3, R2=Ph, and in LA1542, R1=CD3, R2=CD2CF3,
LA1549 through LA1568 having the structure
wherein in LA1549, R1═R2=Me, in LA1550, R1═R2=Et, in LA1551, R1=11′ iPr, in LA1552, R1=Me, R2=Et, in LA1553, R1=Me, R2=iPr, in LA1554, R1=Et, R2=iPr, in LA1555, R1=Me, R2=Ph, in LA1556, R1=Et, R2=Ph, in LA1557, R1═R2=Ph, in LA1558, R1═R2═F, in LA1559, R1=Me, R2═CH2CF3, in LA1560, R1═R2=CD3, in LA1561, R1═R2=CD2CD3, in LA1562, R1═R2=CD(CH3)2, in LA1563, R1=CD3, R2=CD2CD3, in LA1564, R1=CD3, R2=CD(CH3)2, in LA1565, R1=CD2CD3, R2=CD(CH3)2, in LA1566, R1=CD3, R2=Ph, in LA1567, R1=CD2CD3, R2=Ph, and in LA1568, R1=CD3, R2=CD2CF3,
LA1569 through LA1588 having the structure
wherein in LA1569, R1═R2=Me, in LA1570, R1═R2=Et, in LA1571, R1=R2=iPr, in LA1572, R1=Me, R2=Et, in LA1573, R1=Me, R2=iPr, in LA1574, R1=Et, R2=iPr, in LA1575, R1=Me, R2=Ph, in LA1576, R1=Et, R2=Ph, in LA1577, R1═R2=Ph, in LA1578, R1═R2═F, in LA1579, R1=Me, R2═CH2CF3, in LA1580, R1═R2=CD3, in LA1581, R1═R2=CD2CD3, in LA1582, R1═R2=CD(CH3)2, in LA1583, R1=CD3, R2=CD2CD3, in LA1584, R1=CD3, R2=CD(CH3)2, in LA1585, R1=CD2CD3, R2=CD(CH3)2, in LA1586, R1=CD3, R2=Ph, in LA1587, R1=CD2CD3, R2=Ph, and in LA1588, R1=CD3, R2=CD2CF3,
LA1595 through LA1614 having the structure
wherein in LA1595, R1═R2=Me, in LA1596, R2=Et, in LA1599, R1=Me, R2=iPr, in LA1600, R1=Et, R1═R2=Et, in LA1597, R1═R iPr in L R2=iPr, in LA1601, R1=Me, R2=Ph, in LA1602, R1=Et, R2=Ph, in LA1603, R1═R2=Ph, in LA1604, R1═R2═F, in LA1605, R1=Me, R2═CH2CF3, in LA1606, R1═R2=CD3, in LA1607, R1═R2=CD2CD3, in LA1608, R1═R2=CD(CH3)2, in LA1609, R1=CD3, R2=CD2CD3, in LA1610, R1=CD3, R2=CD(CH3)2, in LA1611, R1=CD2CD3, R2=CD(CH3)2, in LA1612, R1=CD3, R2=Ph, in LA1613, R1=CD2CD3, R2=Ph, and in LA1614, R1=CD3, R2=CD2CF3,
LA1621 through LA1640 having the structure
wherein in LA1621, R1═R2=Me, in LA1622, R1═R2=Et, in LA1623, R1═R2=iPr, in LA1624, R1=Me, R2=Et, in LA1625, R1=Me, R2=iPr, in LA1626, R1=Et, R2=iPr, in LA1627, R1=Me, R2=Ph, in LA1628, R1=Et, R2=Ph, in LA1629, R1═R2=Ph, in LA1630, R1═R2═F, in LA1631, R1=Me, R2═CH2CF3, in LA1632, R1═R2=CD3, in LA1633, R1═R2=CD2CD3, in LA1634, R1═R2=CD(CH3)2, in LA1635, R1=CD3, R2=CD2CD3, in LA1636, R1=CD3, R2=CD(CH3)2, in LA1637, R1=CD2CD3, R2=CD(CH3)2, in LA1638, R1=CD3, R2=Ph, in LA1639, R1=CD2CD3, R2=Ph, and in LA1640, R1=CD3, R2=CD2CF3,
LA1647 through LA1666 having the structure
wherein in LA1647, R1═R2=Me, in LA1648, R1═R2=Et, in LA1649, R1═R2=iPr, in LA1650, R1=Me, R2=Et, in LA1651, R1=Me, R2=iPr, in LA1652, R1=Et, R2=iPr, in LA1653, R1=Me, R2=Ph, in LA1654, R1=Et, R2=Ph, in LA1655, R1═R2=Ph, in LA1656, R1═R2═F, in LA1657, R1=Me, R2═CH2CF3, in LA1658, R1═R2=CD3, in LA1659, R1═R2=CD2CD3, in LA1660, R1═R2=CD(CH3)2, in LA1661, R1=CD3, R2=CD2CD3, in LA1662, R1=CD3, R2-CD(CH3)2, in LA1663, R1=CD2CD3, R2=CD(CH3)2, in LA1664, R1=CD3, R2=Ph, in LA1665, R1=CD2CD3, R2=Ph, and in LA1666, R1=CD3, R2=CD2CF3,
LA1673 through LA1692 having the structure
wherein in LA1673, R1═R2=Me, in LA1674, R1═R2=Et, in LA1675, R1═R2=iPr, in LA1676, R1=Me, R2=Et, in LA1677, R1=Me, R2=iPr, in LA1678, R1=Et, R2=iPr, in LA1679, R1=Me, R2=Ph, in LA1680, R1=Et, R2=Ph, in LA1681=R1═R2=Ph, in LA1682, R1═R2═F, in LA1683, R1=Me, R2═CH2CF3, in LA1684, R1═R2=CD3, in LA1685, R1═R2=CD2CD3, in LA1686, R1═R2=CD(CH3)2, in LA1687, R1=CD3, R2=CD2CD3, in LA1688, R1=CD3, R2-CD(CH3)2, in LA1689, R1=CD2CD3, R2=CD(CH3)2, in LA1690, R1=CD3, R2=Ph, in LA1691, R1=CD2CD3, R2=Ph, and in LA1692, R1=CD3, R2=CD2CF3,
LA1699 through LA1718 having the structure
wherein in LA1699, R1═R2=Me, in LA1700, R1═R2=Et, in LA1701, R1═R2=iPr, in LA1702, R1=Me, R2=Et, in LA1703, R1=Me, R2=iPr, in LA1704, R1=Et, R2=iPr, in LA1705, R1=Me, R2=Ph, in LA1706, R2=Ph, in LA1707, R1═R2=Ph, in LA1708, R1═R2═F, in LA1709, R1=Me, R2═CH2CF3, in LA1710, R1═R2=CD3, in LA1711, R1═R2=CD2CD3, in LA1712, R1═R2=CD(CH3)2, in LA1713, R1=CD3, R2=CD2CD3, in LA1714, R1=CD3, R2=CD(CH3)2, in LA1715, R1=CD2CD3, R2=CD(CH3)2, in LA1716, R1=CD3, R2=Ph, in LA1717, R1=CD2CD3, R2=Ph, and in LA1718, R1=CD3, R2=CD2CF3,
LA1719 through LA1738 having the structure
wherein in LA1719, R1═R2=Me, in LA1720, R1═R2=Et, in LA1721, R1═R2=iPr, in LA1722, R1=Me, R2=Et, in LA1723, R1=Me, R2=iPr, in LA1724, R1=Et, R2=iPr, in LA1725, R1=Me, R2=Ph, in LA1726, R1=Et, R2=Ph, in LA1727, R1═R2=Ph, in LA1728, R1═R2═F, in LA1729, R1=Me, R2═CH2CF3, in LA1730, R1═R2=CD3, in LA1731, R1═R2=CD2CD3, in LA1732, R1═R2=CD(CH3)2, in LA1733, R1=CD3, R2=CD2CD3, in LA1734, R1=CD3, R2=CD(CH3)2, in LA1735, R1=CD2CD3, R2=CD(CH3)2, in LA1736, R1=CD3, R2=Ph, in LA1737, R1=CD2CD3, R2=Ph, and in LA1738, R1=CD3, R2=CD2CF3,
LA1745 through LA1764 having the structure
wherein in LA1745, R1═R2=Me, in LA1746, R1═R2=Et, in LA1747, R1═R2=iPr, in LA1748, R1=Me, R2=Et, in LA1749, R1=Me, R2=iPr, in LA1750, R1=Et, R2=iPr, in LA1751, R1=Me, R2=Ph, in LA1752, R1=Et, R2=Ph, in LA1753, R1═R2=Ph, in LA1754, R1═R2═F, in LA1755, R1=Me, R2═CH2CF3, in LA1756, R1═R2=CD3, in LA1757, R1═R2=CD2CD3, in LA1758, R1═R2=CD(CH3)2, in LA1759, R1=CD3, R2=CD2CD3, in LA1760, R1=CD3, R2=CD(CH3)2, in LA1761, R1=CD2CD3, R2=CD(CH3)2, in LA1762, R1=CD3, R2=Ph, in LA1763, R1=CD2CD3, R2=Ph, and in LA1764, R1=CD3, R2=CD2CF3,
LA1771 through LA1790 having the structure
wherein in LA1771, R1═R2=Me, in LA1772, R1═R2=Et, in LA1773, R1═R2=iPr, in LA1774, R1=Me, R2=Et, in LA1775, R1=Me, R2=iPr, in LA1776, R1=Et, R2=iPr, in LA1777, R1=Me, R2=Ph, in LA1778, R1=Et, R2=Ph, in LA1779, R1═R2=Ph, in LA1780, R1═R2═F, in LA1781, R1=Me, R2═CH2CF3, in LA1782, R1═R2=CD3, in LA1783, R1═R2=CD2CD3, in LA1784, R1═R2=CD(CH3)2, in LA1785, R1=CD3, R2=CD2CD3, in LA1786, R1=CD3, R2=CD(CH3)2, in LA1787, R1=CD2CD3, R2=CD(CH3)2, in LA1788, R1=CD3, R2=Ph, in LA1789, R1=CD2CD3, R2=Ph, and in LA1790, R1=CD3, R2=CD2CF3,
LA1797 through LA1816 having the structure
wherein in LA1797, R1═R2=Me, in LA1798, R1═R2=Et, in LA1799, R1═R2=iPr, in LA1800, R1=Me, R2=Et, in LA1801, R1=Me, R2=iPr, in LA1802, R1=Et, R2=iPr, in LA1803, R1=Me, R2=Ph, in LA1804, R1=Et, R2=Ph, in LA1805, R1═R2=Ph, in LA1806, R1═R2═F, in LA1807, R1=Me, R2═CH2CF3, in LA1808, R1═R2=CD3, in LA1809, R1═R2=CD2CD3, in LA1810, R1═R2=CD(CH3)2, in LA1811, R1=CD3, R2=CD2CD3, in LA1812, R1=CD3, R2=CD(CH3)2, in LA1813, R1=CD2CD3, R2=CD(CH3)2, in LA1814, R1=CD3, R2=Ph, in LA1815, R1=CD2CD3, R2=Ph, and in LA1816, R1=CD3, R2=CD2CF3,
LA1823 through LA1842 having the structure
wherein in LA1823, R1═R2=Me, in LA1824, R1═R2=Et, in LA1825, R1═R2=iPr, in LA1826, R1=Me, R2=Et, in LA1827, R1=Me, R2=iPr, in LA1828, R1=Et, R2=iPr, in LA1829, R1=Me, R2=Ph, in LA1830, R1=Et, R2=Ph, in LA1831, R1═R2=Ph, in LA1832, R1═R2═F, in LA1833, R1=Me, R2═CH2CF3, in LA1834, R1═R2=CD3, in LA1835, R1═R2=CD2CD3, in LA1836, R1═R2=CD(CH3)2, in LA1837, R1=CD3, R2=CD2CD3, in LA1838, R1=CD3, R2=CD(CH3)2, in LA1839, R1=CD2CD3, R2=CD(CH3)2, in LA1840, R1=CD3, R2=Ph, in LA1841, R1=CD2CD3, R2=Ph, and in LA1842, R1=CD3, R2=CD2CF3,
LA1849 through LA1868 having the structure
wherein in LA1849, R1═R2=Me, in LA1850, R1═R2=Et, in LA1851, R1═R2=iPr, in LA1852, R1=Me, R2=Et, in LA1853, R1=Me, R2=iPr, in LA1854, R1=Et, R2=iPr, in LA1855, R1=Me, R2=Ph, in LA1856, R1=Et, R2=Ph, in LA1857, R1═R2=Ph, in LA1858, R1═R2═F, in LA1859, R1=Me, R2═CH2CF3, in LA1860, R1═R2=CD3, in LA1861, R1═R2=CD2CD3, in LA1862, R1═R2=CD(CH3)2, in LA1863, R1=CD3, R2=CD2CD3, in LA1864, R1=CD3, R2=CD(CH3)2, in LA1865, R1=CD2CD3, R2=CD(CH3)2, in LA1866, R1=CD3, R2=Ph, in LA1867, R1=CD2CD3, R2=Ph, and in LA1868, R1=CD3, R2=CD2CF3,
LA1869 through LA1888 having the structure
wherein in LA1869, R1═R2=Me, in LA1870, R1═R2=Et, in LA1871, R1═R2=iPr, in LA1872, R1=Me, R2=Et, in LA1873, R1=Me, R2=iPr, in LA1874, R1=Et, R2=iPr, in LA1875, R1=Me, R2=Ph, in LA1876, R1=Et, R2=Ph, in LA1877, R1═R2=Ph, in LA1878, R1═R2═F, in LA1879, R1=Me, R2═CH2CF3, in LA1880, R1═R2=CD3, in LA1881, R1═R2=CD2CD3, in LA1882, R1═R2=CD(CH3)2, in LA1883, R1=CD3, R2=CD2CD3, in LA1884, R1=CD3, R2=CD(CH3)2, in LA1885, R1=CD2CD3, R2=CD(CH3)2, in LA1886, R1=CD3, R2=Ph, in LA1887, R1=CD2CD3, R2=Ph, and in LA1888, R1=CD3, R2=CD2CF3,
LA1895 through LA1914 having the structure
wherein in LA1895, R1═R2=Me, in LA1896, R1═R2=Et, in LA1897, R1═R2=iPr in LA1898, R1=Me, R2=Et, in LA1899, R1=Me, R2=iPr, in LA1900, R1=Et, R2=iPr, in LA1901, R1=Me, R2=Ph, in LA1902, R1=Et, R2=Ph, in LA1903, R1═R2=Ph, in LA1904, R1═R2═F, in LA1905, R1=Me, R2═CH2CF3, in LA1906, R1═R2=CD3, in LA1907, R1═R2=CD2CD3, in LA1908, R1═R2=CD(CH3)2, in LA1909, R1=CD3, R2=CD2CD3, in LA1910, R1=CD3, R2=CD(CH3)2, in LA1911, R1=CD2CD3, R2=CD(CH3)2, in LA1912, R1=CD3, R2=Ph, in LA1913, R1=CD2CD3, R2=Ph, and in LA1914, R1=CD3, R2=CD2CF3,
LA1921 through LA1940 having the structure
wherein in LA1921, R1═R2=Me, in LA1922, R1═R2=Et, in LA1923, R1═R2=iPr, in LA1924, R1=Me, R2=Et, in LA1925, R1=Me, R2=iPr, in LA1926, R1=Et, R2=iPr, in LA1927, R1=Me, R2=Ph, in LA1928, R1=Et, R2=Ph, in LA1929, R1═R2=Ph, in LA1930, R1═R2═F, in LA1931, R1=Me, R2═CH2CF3, in LA1932, R1═R2=CD3, in LA1933, R1═R2=CD2CD3, in LA1934, R1═R2=CD(CH3)2, in LA1935, R1=CD3, R2=CD2CD3, in LA1936, R1=CD3, R2=CD(CH3)2, in LA1937, R1=CD2CD3, R2=CD(CH3)2, in LA1938, R1=CD3, R2=Ph, in LA1939, R1=CD2CD3, R2=Ph, and in LA1940, R1=CD3, R2=CD2CF3,
LA1947 through LA1966 having the structure
wherein in LA1947, R1═R2=Me, in LA1948, R1═R2=Et, in LA1949, R1═R2=iPr, in LA1950, R1=Me, R2=Et, in LA1951, R1=Me, R2=iPr, in LA1952, R1=Et, R2=iPr, in LA1953, R1=Me, R2=Ph, in LA1954, R1=Et, R2=Ph, in LA1955, R1═R2=Ph, in LA1956, R1═R2═F, in LA1957, R1=Me, R2═CH2CF3, in LA1958, R1═R2=CD3, in LA1959, R1═R2=CD2CD3, in LA1960, R1═R2=CD(CH3)2, in LA1961, R1=CD3, R2=CD2CD3, in LA1962, R1=CD3, R2=CD(CH3)2, in LA1963, R1=CD2CD3, R2=CD(CH3)2, in LA1964, R1=CD3, R2=Ph, in LA1965, R1=CD2CD3, R2=Ph, and in LA1966, R1=CD3, R2=CD2CF3,
LA1973 through LA1992 having the structure
wherein in LA1973, R1═R2=Me, in LA1974, R1═R2=Et, in LA1975, R1═R2=iPr, in LA1976, R1=Me, R2=Et, in LA1977, R1=Me, R2=iPr, in LA1978, R1=Et, R2=iPr, in LA1979, R1=Me, R2=Ph, in LA1980, R1=Et, R2=Ph, in LA1981, R1═R2=Ph, in LA1982, R1═R2═F, in LA1983, R1=Me, R2═CH2CF3, in LA1984, R1═R2=CD3, in LA1985, R1═R2=CD2CD3, in LA1986, R1═R2=CD(CH3)2, in LA1987, R1=CD3, R2=CD2CD3, in LA1988, R1=CD3, R2=CD(CH3)2, in LA1989, R1=CD2CD3, R2=CD(CH3)2, in LA1990, R1=CD3, R2=Ph, in LA1991, R1=CD2CD3, R2=Ph, and in LA1992, R1=CD3, R2=CD2CF3,
LA1999 through LA2018 having the structure
wherein in LA1999, R1═R2=Me, in LA2000, R1═R2=Et, in LA2001, R1═R2=iPr, in LA2002, R1=Me, R2=Et, in LA2003, R1=Me, R2=iPr, in LA2004, R1=Et, R2=iPr, in LA2005, R1=Me, R2=Ph, in LA2006, R2=Ph, in LA2007, R1═R2=Ph, in LA2008, R1═R2═F, in LA2009, R1=Me, R2═CH2CF3, in LA2010, R1═R2=CD3, in LA2011, R1═R2=CD2CD3, in LA2012, R1═R2=CD(CH3)2, in LA2013, R1=CD3, R2=CD2CD3, in LA2014, R1=CD3, R2=CD(CH3)2, in LA2015, R1=CD2CD3, R2=CD(CH3)2, in LA2016, R1=CD3, R2=Ph, in LA2017, R1=CD2CD3, R2=Ph, and in LA2018, R1=CD3, R2=CD2CF3,
LA2019 through LA1842 having the structure
wherein in LA2019, R1═R2=Me, in LA2020, R1═R2=Et, in LA2021, R1═R2=iPr, in LA2022, R1=Me, R2=Et, in LA2023, R1=Me, R2=iPr, in LA2024, R1=Et, R2=iPr, in LA2025, R1=Me, R2=Ph, in LA2026, R1=Et, R2=Ph, in LA2027, R1═R2=Ph, in LA2028, R1═R2═F, in LA2029, R1=Me, R2═CH2CF3, in LA2030, R1═R2=CD3, in LA2031, R1═R2=CD2CD3, in LA2032, R1═R2=CD(CH3)2, in LA2033, R1=CD3, R2=CD2CD3, in LA2034, R1=CD3, R2=CD(CH3)2, in LA2035, R1=CD2CD3, R2=CD(CH3)2, in LA2036, R1=CD3, R2=Ph, in LA2037, R1=CD2CD3, R2=Ph, and in LA2038, R1=CD3, R2=CD2CF3,
LA2045 through LA2064 having the structure
wherein in LA2045, R1═R2=Me, in LA2046, R1═R2=Et, in LA2047, R1═R2=iPr, in LA2048, R1=Me, R2=Et, in LA2049, R1=Me, R2=iPr, in LA2050, R1=Et, R2=iPr, in LA2051, R1=Me, R2=Ph, in LA2052, R1=Et, R2=Ph, in LA2053, R1═R2=Ph, in LA2054, R1═R2═F, in LA2055, R1=Me, R2═CH2CF3, in LA2056, R1═R2=CD3, in LA2057, R1═R2=CD2CD3, in LA2058, R1═R2=CD(CH3)2, in LA2059, R1=CD3, R2=CD2CD3, in LA2060, R1=CD3, R2=CD(CH3)2, in LA2061, R1=CD2CD3, R2=CD(CH3)2, in LA2062, R1=CD3, R2=Ph, in LA2063, R1=CD2CD3, R2=Ph, and in LA2064, R1=CD3, R2=CD2CF3,
LA2071 through LA2090 having the structure
wherein in LA2071, R1═R2=Me, in LA2072, R1═R2=Et, in LA2073, R1═R2=iPr, in LA2074, R1=Me, R2=Et, in LA2075, R1=Me, R2=iPr, in LA2076, R1=Et, R2=iPr, in LA2077, R1=Me, R2=Ph, in LA2078, R1=Et, R2=Ph, in LA2079=R1═R2=Ph, in LA2080, R1═R2═F, in LA2081, R1=Me, R2═CH2CF3, in LA2082, R1═R2=CD3, in LA2083, R1═R2=CD2CD3, in LA2084, R1═R2=CD(CH3)2, in LA2085, R1=CD3, R2=CD2CD3, in LA2086, R1=CD3, R2=CD(CH3)2, in LA2087, R1=CD2CD3, R2=CD(CH3)2, in LA2088, R1=CD3, R2=Ph, in LA2089, R1=CD2CD3, R2=Ph, and in LA2090, R1=CD3, R2=CD2CF3,
LA2097 through LA2116 having the structure
wherein in LA2097, R1═R2=Me, in LA2098, R1═R2=Et, in LA2099, R1═R2=iPr, in LA2100, R1=Me, R2=Et, in LA2101, R1=Me, R2=iPr, in LA2102, R1=Et, R2=iPr, in LA2103, R1=Me, R2=Ph, in LA2104, R1=Et, R2=Ph, in LA2105, R1═R2=Ph, in LA2106, R1═R2═F, in LA2107, R1=Me, R2═CH2CF3, in LA2108, R1═R2=CD3, in LA2109, R1═R2=CD2CD3, in LA2110, R1═R2=CD(CH3)2, in LA2111, R1=CD3, R2=CD2CD3, in LA2112, R1=CD3, R2=CD(CH3)2, in LA2113, R1=CD2CD3, R2=CD(CH3)2, in LA2114, R1=CD3, R2=Ph, in LA2115, R1=CD2CD3, R2=Ph, and in LA2116, R1=CD3, R2=CD2CF3,
LA2123 through LA2142 having the structure
wherein in LA2123, R1═R2=Me, in LA2124, R1═R2=Et, in LA2125, R1═R2=iPr, in LA2126, R1=Me, R2=Et, in LA2127, R1=Me, R2=iPr, in LA2128, R1=Et, R2=iPr, in LA2129, R1=Me, R2=Ph, in LA2130, R1=Et, R2=Ph, in LA2131, R1═R2=Ph in LA2132, R1═R2═F, in LA2133, R1=Me, R2═CH2CF3, in LA2134, R1═R2=CD3, in LA2135, R1═R2=CD2CD3, in LA2136, R1═R2=CD(CH3)2, in LA2137, R1=CD3, R2=CD2CD3, in LA2138, R1=CD3, R2=CD(CH3)2, in LA2139, R1=CD2CD3, R2=CD(CH3)2, in LA2140, R1=CD3, R2=Ph, in LA2141, R1=CD2CD3, R2=Ph, and in LA2142, R1=CD3, R2=CD2CF3,
LA2149 through LA2168 having the structure
wherein in LA2149, R1═R2=Me, in LA2150, R1═R2=Et, in LA2151, R1═R2=iPr, in LA2152, R1=Me, R2=Et, in LA2153, R1=Me, R2=iPr, in LA2154, R1=Et, R2=iPr, in LA2155, R1=Me, R2=Ph, in LA2156, R1=Et, R2=Ph, in LA2157, R1═R2=Ph, in LA2158, R1═R2═F, in LA2159, R1=Me, R2═CH2CF3, in LA2160, R1═R2=CD3, in LA2161, R1═R2=CD2CD3, in LA2162, R1═R2=CD(CH3)2, in LA2163, R1=CD3, R2=CD2CD3, in LA2164, R1=CD3, R2=CD(CH3)2, in LA2165, R1=CD2CD3, R2=CD(CH3)2, in LA2166, R1=CD3, R2=Ph, in LA2167, R1=CD2CD3, R2=Ph, and in LA2168, R1=CD3, R2=CD2CF3,
LA2169 through LA2188 having the structure
wherein in LA2169, R1═R2=Me, in LA2170, R1═R2=Et, in LA2171, R1═R2=iPr, in LA2172, R1=Me, R2=Et, in LA2173, R1=Me, R2=iPr, in LA2174, R1=Et, R2=iPr, in LA2175, R1=Me, R2=Ph, in LA2176, R1=Et, R2=Ph, in LA2177, R1═R2=Ph, in LA2178, R1═R2═F, in LA2179, R1=Me, R2═CH2CF3, in LA2180, R1═R2=CD3, in LA2181, R1═R2=CD2CD3, in LA2182, R1═R2=CD(CH3)2, in LA2183, R1=CD3, R2=CD2CD3, in LA2184, R1=CD3, R2=CD(CH3)2, in LA2185, R1=CD2CD3, R2=CD(CH3)2, in LA2186, R1=CD3, R2=Ph, in LA2187, R1=CD2CD3, R2=Ph, and in LA2188, R1=CD3, R2=CD2CF3,
LA2195 through LA2214 having the structure
wherein in LA2195, R1═R2=Me, in LA2196, R1═R2=Et, in LA2197, R1═R2=iPr, in LA2198, R1=Me, R2=Et, in LA2199, R1=Me, R2=iPr, in LA2200, R1=Et, R2=iPr, in LA2201, R1=Me, R2=Ph, in LA2202, R1=Et, R2=Ph, in LA2203, R1═R2=Ph, in LA2204, R1═R2═F, in LA2205, R1=Me, R2═CH2CF3, in LA2206, R1═R2=CD3, in LA2207, R1═R2=CD2CD3, in LA2208, R1═R2=CD(CH3)2, in LA2209, R1=CD3, R2=CD2CD3, in LA2210, R1=CD3, R2=CD(CH3)2, in LA2211, R1=CD2CD3, R2=CD(CH3)2, in LA2212, R1=CD3, R2=Ph, in LA2213, R1=CD2CD3, R2=Ph, and in LA2214, R1=CD3, R2=CD2CF3,
LA2221 through LA2240 having the structure
wherein in LA2221, R1═R2=Me, in LA2222, R1═R2=Et, in LA2223, R1═R2=iPr, in LA2224, R1=Me, R2=Et, in LA2225, R1=Me, R2=iPr, in LA2226, R1=Et, R2=iPr, in LA2227, R1=Me, R2=Ph, in LA2228, R1=Et, R2=Ph, in LA2229, R1═R2=Ph, in LA2230, R1═R2═F, in LA2231, R1=Me, R2═CH2CF3, in LA2232, R1═R2=CD3, in LA2233, R1═R2=CD2CD3, in LA2234, R1═R2=CD(CH3)2, in LA2235, R1=CD3, R2=CD2CD3, in LA2236, R1=CD3, R2=CD(CH3)2, in LA2237, R1=CD2CD3, R2=CD(CH3)2, in LA2238, R1=CD3, R2=Ph, in LA2239, R1=CD2CD3, R2=Ph, and in LA2240, R1=CD3, R2=CD2CF3,
LA2247 through LA2266 having the structure
wherein in LA2247, R1═R2=Me, in LA2248, R1═R2=Et, in LA2249, R1═R2=iPr, in LA2250, R1=Me, R2=Et, in LA2251, R1=Me, R2=iPr, in LA2252, R1=Et, R2=iPr, in LA2253, R1=Me, R2=Ph, in LA2254, R1=Et, R2=Ph, in LA2255, R1═R2=Ph, in LA2256, R1═R2═F, in LA2257, R1=Me, R2═CH2CF3, in LA2258, R1═R2=CD3, in LA2259, R1═R2=CD2CD3, in LA2260, R1═R2=CD(CH3)2, in LA2261, R1=CD3, R2=CD2CD3, in LA2262, R1=CD3, R2=CD(CH3)2, in LA2263, R1=CD2CD3, R2=CD(CH3)2, in LA2264, R1=CD3, R2=Ph, in LA2265, R1=CD2CD3, R2=Ph, and in LA2266, R1=CD3, R2=CD2CF3,
LA2273 through LA2292 having the structure
wherein in LA2273, R1═R2=Me, in LA2274, R1═R2=Et, in LA2275, R1═R2=iPr, in LA2276, R1=Me, R2=Et, in LA2277, R1=Me, R2=iPr, in LA2278, R1=Et, R2=iPr, in LA2279, R1=Me, R2=Ph, in LA2280, R2=Ph, in LA2281, R1═R2=Ph, in LA2282, R1═R2═F, in LA2283, R1=Me, R2═CH2CF3, in LA2284, R1═R2=CD3, in LA2285, R1═R2=CD2CD3, in LA2286, R1═R2=CD(CH3)2, in LA2287, R1=CD3, R2=CD2CD3, in LA2288, R1=CD3, R2=CD(CH3)2, in LA2289, R1=CD2CD3, R2=CD(CH3)2, in LA2290, R1=CD3, R2=Ph, in LA2291, R1=CD2CD3, R2=Ph, and in LA2292, R1=CD3, R2=CD2CF3,
LA2299 through LA1842 having the structure
wherein in LA2299, R1═R2=Me, in LA2300, R1═R2=Et, in LA2301, R1═R2=iPr, in LA2302, R1=Me, R2=Et, in LA2303, R1=Me, R2=iPr, in LA2304, R1=Et, R2=iPr, in LA2305, R1=Me, R2=Ph, in LA2306, R2=Ph, in LA2307, R1═R2=Ph, in LA2308, R1═R2═F, in LA2309, R1=Me, R2═CH2CF3, in LA2310, R1═R2=CD3, in LA2311, R1═R2=CD2CD3, in LA2312, R1═R2=CD(CH3)2, in LA2313, R1=CD3, R2=CD2CD3, in LA2314, R1=CD3, R2=CD(CH3)2, in LA2315, R1=CD2CD3, R2=CD(CH3)2, in LA2316, R1=CD3, R2=Ph, in LA2317, R1=CD2CD3, R2=Ph, and in LA2318, R1=CD3, R2=CD2CF3,
LA2319 through LA2338 having the structure
wherein in LA2319, R1═R2=Me, in LA2320, R1═R2=Et, in LA2321, R1═R2=iPr, in LA2322, R1=Me, R2=Et, in LA2323, R1=Me, R2=iPr, in LA2324, R1=Et, R2=iPr, in LA2325, R1=Me, R2=Ph, in LA2326, R1=Et, R2=Ph, in LA2327, R1═R2=Ph, in LA2328, R1═R2═F, in LA2329, R1=Me, R2═CH2CF3, in LA2330, R1═R2=CD3, in LA2331, R1═R2=CD2CD3, in LA2332, R1═R2=CD(CH3)2, in LA2333, R1=CD3, R2=CD2CD3, in LA2334, R1=CD3, R2=CD(CH3)2, in LA2335, R1=CD2CD3, R2=CD(CH3)2, in LA2336, R1=CD3, R2=Ph, in LA2337, R1=CD2CD3, R2=Ph, and in LA2338, R1=CD3, R2=CD2CF3,
In some embodiments of the compound having the first ligand LA of Formula I, the compound has a formula of M(LA)x(LB)y(LC)z; LB and LC are each a bidentate ligand; and wherein x is 1, 2, or 3; y is 1 or 2; z is 0, 1, or 2; and x+y+z is the oxidation state of the metal M.
In some embodiments of the compound, the compound has a formula selected from the group consisting of Ir(LA)3, Ir(LA)(LB)2, Ir(LA)2(LB), and Ir(LA)(LB)(LC); and LA, LB, and LC are different from each other.
In some embodiments of the compound, the compound has a formula of Pt(LA)(LB), where LA and LB can be same or different. In some embodiments, LA and LB are connected to form a tetradentate ligand. In some embodiments, LA and LB are connected at two places to form a macrocyclic tetradentate ligand.
In some embodiments of the compound having the formula of M(LA)x(LB)y(LC)z, LB and LC are each independently selected from the group consisting of:
wherein each Y1 to Y13 are independently selected from the group consisting of carbon and nitrogen; wherein Y′ is selected from the group consisting of BRe, NRe, PRe, O, S, Se, C═O, S═O, SO2, CReRfRR, SiReRf, and GeReRf; wherein Re and Rf are optionally fused or joined to form a ring; wherein each Ra, Rb, Rc, and Rd may independently represent from mono substitution to the maximum possible number of substitution, or no substitution; wherein each R, Ra, Rb, Rc, Rd, Re and Rf is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents of Ra, Rb, Rc, and Rd are optionally fused or joined to form a ring or form a multidentate ligand. In some embodiments, each R, Ra, Rb, Rc, Rd, Re and Rf is independently selected from the group consisting of hydrogen, deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, and combinations thereof.
In some embodiments of the compound having the formula of M(LA)x(LB)y(LC)z, LA is a ligand of Formula I, and LB and LC are each independently selected from the group consisting of:
In some embodiments of the compound having the first ligand LA selected from the group consisting of LA1 to LA2349, the compound is selected from the group consisting of Compound Ax having the formula Ir(LAi)3; wherein x is an integer from 1 to 2349 and i=x.
In some embodiments of the compound having the first ligand LA selected from the group consisting of LA1 to LA2349, the compound is selected from the group consisting of Compound By having the formula Ir(LAi)(LBk)2; wherein y is an integer defined by y=23491+k−2349; wherein i is an integer from 1 to 2349, and k is an integer from 1 to 460; and wherein LBk has the following structures:
An organic light emitting device (OLED) incorporating the compound of the present disclosure is also disclosed. The OLED comprises an anode, a cathode, and an organic layer, disposed between the anode and the cathode. The organic layer comprises a compound comprising a first ligand LA of Formula I,
is disclosed. In Formula I, ring A is a 5- or 6-membered carbocyclic or heterocyclic ring. Each of RA and RB independently represents none to a maximum possible number of substitutions. Each of R1, R2, RA, and RB is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. Z1 is carbon or nitrogen. Any R1, R2, RA, and RB are optionally joined or fused into a ring. The ligand LA is coordinated to a metal M. LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand. M is optionally coordinated to other ligands.
A consumer product comprising the OLED is also disclosed, wherein the organic layer in the OLED comprises the compound comprising the first ligand LA having the Formula I.
In some embodiments, the OLED has one or more characteristics selected from the group consisting of being flexible, being rollable, being foldable, being stretchable, and being curved. In some embodiments, the OLED is transparent or semi-transparent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.
In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED comprises a RGB pixel arrangement or white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a hand held device, or a wearable device. In some embodiments, the OLED is a display panel having less than 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a display panel having at least 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a lighting panel.
An emissive region in an OLED is also disclosed. The emissive region comprises a compound comprising a first ligand LA of Formula I:
is disclosed. In Formula I, ring A is a 5- or 6-membered carbocyclic or heterocyclic ring. Each of RA and RB independently represents none to a maximum possible number of substitutions. Each of R1, R2, RA, and RB is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. Z1 is carbon or nitrogen. Any R1, R2, RA, and RB are optionally joined or fused into a ring. The ligand LA is coordinated to a metal M. LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand. M is optionally coordinated to other ligands.
In some embodiments of the emissive region, the compound is an emissive dopant or a non-emissive dopant.
In some embodiments of the emissive region, the emissive region further comprises a host, wherein the host comprises at least one selected from the group consisting of metal complex, triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, aza-triphenylene, aza-carbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
In some embodiments of the emissive region, the host is selected from the group consisting of:
and combinations thereof.
In some embodiments, the compound can be an emissive dopant. In some embodiments, the compound can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.
According to another aspect, a formulation comprising the compound described herein is also disclosed.
The OLED disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.
The organic layer can also include a host. In some embodiments, two or more hosts are preferred. In some embodiments, the hosts used maybe a) bipolar, b) electron transporting, c) hole transporting or d) wide band gap materials that play little role in charge transport. In some embodiments, the host can include a metal complex. The host can be a triphenylene containing benzo-fused thiophene or benzo-fused furan. Any substituent in the host can be an unfused substituent independently selected from the group consisting of CnH2+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡C—CnH2n+1, Ar1, Ar1—Ar2, and CnH2n—Ar1, or the host has no substitutions. In the preceding substituents n can range from 1 to 10; and Ar1 and Ar2 can be independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. The host can be an inorganic compound. For example a Zn containing inorganic material e.g. ZnS.
The host can be a compound comprising at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene. The host can include a metal complex. The host can be, but is not limited to, a specific compound selected from the group consisting of:
and combinations thereof.
Additional information on possible hosts is provided below.
In yet another aspect of the present disclosure, a formulation that comprises the novel compound disclosed herein is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, and an electron transport layer material, disclosed herein.
Combination with Other Materials
The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.
Conductivity Dopants:
A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer.
Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804 and US2012146012.
HIL/HTL:
A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoOx; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.
Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:
Each of Ar1 to Ar9 is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, Ar1 to Ar9 is independently selected from the group consisting of:
wherein k is an integer from 1 to 20; X101 to X108 is C (including CH) or N; Z101 is NAr1, O, or S; has the same group defined above.
Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:
wherein Met is a metal, which can have an atomic weight greater than 40; (Y101-Y102) is a bidentate ligand, Y101 and Y102 are independently selected from C, N, O, P, and S; L101 is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.
In one aspect, (Y101-Y102) is a 2-phenylpyridine derivative. In another aspect, (Y101-Y102) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc+/Fc couple less than about 0.6 V.
Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Ser. No. 06/517,957, US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. No. 5,061,569, U.S. Pat. No. 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.
EBL:
An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and/or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.
Host:
The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.
Examples of metal complexes used as host are preferred to have the following general formula:
wherein Met is a metal; (Y103-Y104) is a bidentate ligand, Y103 and Y104 are independently selected from C, N, O, P, and S; L101 is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.
In one aspect, the metal complexes are:
wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.
In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y103-Y104) is a carbene ligand.
Examples of other organic compounds used as host are selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each option within each group may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, the host compound contains at least one of the following groups in the molecule:
wherein R101 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20. Xlin to V″ are independently selected from C (including CH) or N. Z101 and Y102 are independently selected from NR101, O, or S.
Non-limiting examples of the host materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472,
Additional Emitters:
One or more additional emitter dopants may be used in conjunction with the compound of the present disclosure. Examples of the additional emitter dopants are not particularly limited, and any compounds may be used as long as the compounds are typically used as emitter materials. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.
Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Ser. No. 06/699,599, U.S. Ser. No. 06/916,554, US20010019782, US20020034656, US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, U.S. Pat. No. 6,303,238, U.S. Pat. No. 6,413,656, U.S. Pat. No. 6,653,654, U.S. Pat. No. 6,670,645, U.S. Pat. No. 6,687,266, U.S. Pat. No. 6,835,469, U.S. Pat. No. 6,921,915, U.S. Pat. No. 7,279,704, U.S. Pat. No. 7,332,232, U.S. Pat. No. 7,378,162, U.S. Pat. No. 7,534,505, U.S. Pat. No. 7,675,228, U.S. Pat. No. 7,728,137, U.S. Pat. No. 7,740,957, U.S. Pat. No. 7,759,489, U.S. Pat. No. 7,951,947, U.S. Pat. No. 8,067,099, U.S. Pat. No. 8,592,586, U.S. Pat. No. 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450.
HBL:
A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.
In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.
In another aspect, compound used in HBL contains at least one of the following groups in the molecule:
wherein k is an integer from 1 to 20; L101 is an another ligand, k′ is an integer from 1 to 3. ETL:
Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.
In one aspect, compound used in ETL contains at least one of the following groups in the molecule:
wherein R101 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar1 to Ar3 has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X101 to Y108 is selected from C (including CH) or N.
In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:
wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.
Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. No. 6,656,612, U.S. Pat. No. 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535,
Charge Generation Layer (CGL)
In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.
In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.
Synthesis of Materials
An example of the inventive compound Ir(LA65)(LB12)2 can be synthesized by the procedure shown in the following scheme:
The imine intermediate (E)-1-(2-bromophenyl)-N-(2-isopropylphenyl)methanimine, which can be prepared by condensation reaction between bromobenzaldehyde and 2-isopropylaniline, can undergo lithiation with n-butyl lithium, addition of acetone, followed by a treatment with trifluomethanesulfonic anhydride, affording the desired isoindolium salt in a one pot procedure. (Angewandte Chemie International Edition 2015, 54, 14915). The isoindolium salt can then be deprotonated using lithium bis(trimethylsilyl)amide at −78° C., in the presence of [Ir(COD)Cl]2 to form Intermediate I shown above. Using a procedure analogous to that described in U.S. Pat. No. 9,487,548B2, the inventive example Ir(LA65)(LB12)2 can be synthesized by mixing a solution of Intermediate I in anhydous o-xylene to a suspension of 1,3-diphenylpyrazinoimidazolium iodide and silver(I) oxide in anhydrous 1,4-dioxane under reflux condition.
Disclosed herein is a series of cyclic aryl amino carbenes as ligands for metal complexes. These ligands have stronger sigma-donating and pi-accepting characters when compared with N-heterocyclic carbenes. As a result of these enhanced innate characters, a stronger metal-carbon bond is formed. A stronger metal-carbon bond is a highly desired property for OLED applications because it helps to strengthen the interaction between the ligand and the metal (in this case Iridium) which is believed to help increase the stability of the metal complexes. Therefore, the inventive compounds when used as emitters can improve the lifetime of the OLED device and also exhibit higher photoluminescence quantum yield.
It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.
This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 62/507,832, filed May 18, 2017, the entire contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62507832 | May 2017 | US |